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ABSTRACT
Nonviral vector research and development has been stunted by a lack of knowledge and
understanding of how vectors are trafficked within the cell. Research currently involves mass
screenings of different combinations of vector components without a true understanding of how
each component interacts with the target cell. Few tools are currently available for scientists to
quantitatively examine these vector-to-cell interactions or determine the rate limiting steps
within the gene delivery pathway. Thus, researchers cannot fully optimize the vector design to
reach maximal delivery efficiency.
This project seeks to address this issue by modifying a density gradient electrophoresis (DGE)
device originally developed on Mel Juso cells to segregate primary rat hepatocyte lysate into
nuclear, early endosomal, late endosomal/lysosomal, and cytoplasmic fractions. We found that
according to the Horseradish Peroxidase assay, late endosomes and lysosomes consistently
localize to fractions 11-13 and early endosomes in fractions 18 to 21. There was minimal
labeling in fractions 14 through 17 demonstrating that separation of the organelles was achieved.
With this higher resolution fractionation, movement through the endosomal pathway can be
studied in greater detail. The rates with which each vector moves from outside of the cell into the
early endosome, to the late endosome, to the cytoplasm and into the nucleus can be quantified.
The steps affected by specific modifications to the vector design and the vector properties most
important for delivery efficiency can be identified. As vectors are sorted differently in different
cell types, this DGE device will allow researchers to gain insight of the cell-specific sorting
mechanisms. Ultimately, DGE can aid design of vectors that reach delivery efficiencies
comparable to viruses and tailor the vectors to the tissue of interest.
Thesis Supervisor: Douglas A Lauffenburger
Title: Whitaker Professor of Bioengineering
Director, Department of Biological Engineering
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1.0 Introduction and Background
The work described in this thesis contributes to the field of non-viral gene therapy, specifically,
in developing an improved approach to the method proposed by Csanad Varga's 2003 MIT
doctoral thesis for determining optimal gene vector design. The results from the project enable
systematic examination of the delivery kinetics of the gene vectors tested and thus, allow a
comprehensive evaluation and comparison of the contributions of various individual vector
properties to the overall delivery efficacy. An understanding of the effects of vector properties on
the delivery kinetics can motivate and guide better vector design.
This introductory chapter gives a brief overview of the limitations of current non-viral gene
therapy research and summarizes the method proposed by Varga for evaluating gene delivery
mechanism and the importance of organelle fractionation for this method. Then, this chapter
compares density gradient electrophoresis, the process chosen for this particular thesis, to other
fractionation methods and systems. The last section details the aims and goals of this thesis.
1.1. Gene Therapy Research
One of the major obstacles to bringing gene therapy into standard medical practice is
difficulties in finding an appropriate vehicle for the gene constructs that is efficient and
effective without sacrificing safety [1, 2].
1.1.1. Viral versus Non-Viral
Viral vectors, often inactivated recombinant viruses with disabled or fully deleted
replication machinery, are very efficient in delivery [2, 3]. However, they often
cause unpredictable, toxic and heightened immune responses [3-5]. It is hard to
determine which antigens will cause an immune response as the immune system
varies widely from individual to individual. Furthermore, while rare,
recombination and mutation events can lead to vectors which once again become
replication competent, a potentially disastrous effect [3, 5]. Inserting even just a
few live viruses could bring great harm to the patients.
While many researchers are still working with modified viruses to make them
safer and less unpredictable, many others are turning to non-viral alternatives [6,
7] whose delivery method can mimic the steps of a viral infection such as rapid
internalization [8]. Non-viral vectors are typically small organic molecules, such
as polycations [9-12], lipids [13-16], carbohydrates, amino acids, [17, 18], or
some combination thereof. They are easier to modify and produce in mass
quantities. They are often less toxic and safer [19] but currently face major
barriers in steps such as endosomal escape and nuclear entry that render the
delivery too inefficient to be effective.
In order to effectively deliver a gene construct, a vector must be able to complex
the therapeutic DNA of interest in stable particulate form, must facilitate the
construct's entry from outside of the cell into the nucleus of the target cell, where
it will either be inserted into the host genome for permanent gene expression or be
transiently expressed epi-chromosomally via a non-integrating plasmid, the latter
being more common for non-viral delivery [12]. Non-viral vector researchers
have currently been unable to achieve the same level of efficiency as viruses due
to an inadequate understanding as to how the interactions between the cells and
vectors in the delivery pathway affect its overall delivery efficiency.
1.1.2. The Endosomal Pathway
A case in point is the endosomal pathway (reviewed in [20-22]), a popular way
for vectors, both viral and non-viral to enter the cell (reviewed in [23, 24]). In the
endosomal pathway, vectors or other materials such as the horseradish peroxidase
used in some of the experiments detailed in this thesis are taken up into the cell
and can enter the cell in two ways. The first is by fluid-phase endocytosis which
happens naturally and the second is by binding to receptors on the cell surface
which causes the cell membrane to deform into pits that are sometimes clathrin
coated. Eventually, the membrane surrounds the ligand and receptors and pinches
off. Either way, the vectors or materials end up inside the cell in a small vesicle
called an early endosome.
The early endosome carries the material through the cytoplasm of the cell, and its
organelle membrane loses some membrane proteins and gains others as it matures
into the late endosome. Sometimes it fuses with other vesicles to gain different
membrane proteins. The contents can be sorted to recycling vesicles which carry
its contents back out to the cell membrane or sorted to late endosomes and
lysosomes. Ideally, the vector of interest can undergo endosomal escape and to
prevent trafficking to the lysosomes [25]. Then it would translocate to the
nucleus so that the gene it carries can be read and transcribed in the nucleus to
have gene expression. For a vector to reach the nucleus effectively, it must
interact with all these different organelles and cell components and be able to pass
each barrier efficiently.
Figure 1. The Endosomal Pathway and Compartments. Upon entering the
cell, the gene vector can travel to many different compartments. The ideal
pathway is going directly from cellular uptake to the early endosomes to the late
endosomes then experiencing endosomal escape, translocation to nucleus,
unpackaging of the vector and ultimately gene expression. [26]
1.1.3. Designing a Vector.
Current methods of designing vectors are incomplete and inefficient in part
because they do not look at the various trafficking pathways and cellular barriers
in a comprehensive way [8]. Research has focused on individual barriers when it
should be studied in a more integrated fashion. Most current researchers also
randomly focus on one step along the process, perhaps the ligand binding affinity
[27] or nuclear translocation, in designing vectors, when the design considerations
should be more systematic and logical. It is important to study how a current
vector design travels in the target cell, identify the weaknesses along the pathway,
where it is least efficient, and then make modifications that are targeted towards
that problem. For example, if the vector can't escape from the endosomes or
unpack properly [28], trying to improve its ligand binding affinity or nuclear
translocation is a moot effort.
Moreover, one design modification that improves one step may hurt another. A
functional group that acts like a proton sponge in the late endosomes or lysosomes
and facilitate vesicular escape may bind to a cytoplasmic protein or another
organelle and prevent nuclear translocation. It is essential to look at how a
particular modification affects the entire process to truly optimize the design
process.
Furthermore, a specific gene vector may be very effective and efficient in one
target cell type and totally ineffective in another target cell type because the
metabolic activities, presentation of surface receptors, or organelle content and
trafficking activity differ from cell type to cell type. Thus, gene vectors should be
customized to the target cell type.
1.1.4. Quantitative Evaluation of Delivery Efficiency
Currently, most research uses only the end gene expression levels as a measure of
vector efficiency and often relegates to screening mass quantities of compounds
instead of proactively designing a cell specific vector. The result is that vectors
go under-appreciated due to a lack of understanding of the rate limiting steps. A
vector that has low end gene expression during screenings may be easily "fixed"
to have very high gene expression if its rate limiting step is pinpointed. A
quantitative, data-driven model for evaluating gene delivery would identify the
rate limiting steps and guide modifications that would lead to the optimal vector
designs for a specific vector prototype.
As described in numerous journal articles [8, 23, 29], each step would be
designated as a particular compartment, such as early endosome, late endosome,
cytoplasm or nucleus. The transitions such as binding, maturation into late
endosomes, or endosomal escape would be modeled as first order rate processes
which translate to a differential rate equation. Combining the entire endosomal
pathway would result in a set of differential equations. Then, the vector would be
tested in the target cell over a series of time points to determine the quantity of the
vector in each compartment at a given time, which would then be entered into the
model to determine the rates of each step. Thus, the rate limiting step for that
particular vector for this cell type would be determined via parameter sensitivity
analysis and this insight could be used to guide future modifications.
This quantitative model would allow scientists to map the movement of vectors
through the cell over time and determine kinetics and dynamics through the
endosomal pathway as well as determine the most rate limiting steps for effective
gene expression. Furthermore, the model would allow evaluation of the level of
improvement achieved by a particular modification and allow for comparison and
prioritization of specific vector characteristics [29]. Ideally, it would predict what
combination of characteristics would be best and also predict the vector behavior
in the target cell and in other cells studied.
1.1.5. Need for Subcellular Fractionation
The major limitation to this quantitative modeling method of designing vectors is
that current subcellular fractionation techniques do not separate organelles at a
sufficient level of resolution. Thus, the entire endosomal system would be
lumped as one compartment with rate constants typically being taken from the
literature and not actually experimentally measured, resulting in only three
compartments: the endosomes, the nucleus, and the cytoplasm. The very simple
model may not be able to provide enough insight for vector design. The low
resolution of organelle separation has thus, hindered researchers from discerning
how specific modifications of a vector affect its endosomal trafficking and its
delivery efficacy. To date only nuclear and whole cell uptake of non-viral vectors
has been successfully quantified and evaluated via such a modeling approach.
It is thus, the aim of this thesis to develop a fractionation process or modify an
existing one that will allow separation of endosomal and lysosomal organelles to
permit higher-resolution quantitative measurement of vector dynamics. The next
section will describe the demands and constraints on the subcellular fractionation
process and then compare the chosen fractionation method with other existing
processes.
1.2. Subcellular Fractionation
It is important to develop a process that can segregate organelles at a resolution high
enough to discern the major components of the endosomal system. In the very least, the
early endosomal and late endosomal/lysosomal populations must be separated from one
another and from the cytoplasmic and nuclear fractions. Many subcellular compartments
share similar physical properties [30], so the process must be rigorous enough to exploit
small physical differences between the different types of endosomal organelles yet gentle
enough such that the organelles are not broken. The vector populations within the
segregated organelles need to remain a true representation of the vector distribution
throughout the cell at the time point being tested.
There are currently five primary methods by which researchers obtain purified organelle
populations as described in the next five sections. Most are covered in a review by
Pasquali et al. [30].
1.2.1. Density Gradient Centrifugation (DGC)
Density gradient centrifugation (DGC) consists of spinning a sample suspended
within a medium of varying densities. The gravitational forces cause the different
organelles in the sample to migrate to different densities. The end position or
density is usually a function of the ratio of lipid to protein content of the organelle
membranes - endosome membranes are typically lipid rich and low density unlike
protein rich mitochondrial membranes [30]. As reviewed in Mullock et al.[31],
centrifugation often uses a sugar base, mostly sucrose or Percoll [32], but also
sometimes Nycodenz [32, 33], Metrixamide, or Ficoll [33],. Density gradient
centrifugation with Percoll is extensively reviewed in Pertoft 1999 [34].
There are two types of centrifugation, equilibrium and non-equilibrium. For
equilibrium centrifugation, layers of different concentrations are carefully placed
on top of one another so that the concentration is increased in a step-wise fashion.
The concentration range and the increments depend on the substance being
fractionated. The sample is usually layered at the very top and then the entire
tube is centrifuged at forces greater than 150,000 g. The particles travel through
the gradient until they reach the point in the gradient at which their density
matches that of the surrounding sugar concentration. This fraction can then be
removed and subjected to further analysis. Non-equilibrium centrifugation is very
similar to the equilibrium form, but the experiment is only run until a particular
time point before the organelle is actually at the correct density. Then the sucrose
is eluted from the bottom of the tube.
DGC is the most conventional and widely used approach and has been used to
isolate a variety of subcellular components such as lysosomes [35], membrane
vesicles, mitochondria [35], nuclei and ribosomes. However, it often requires
multiple spins to obtain the fractions of interest since each spin only does one or
two separations at a time. Isolation of unmodified lysosomes and endosomes
requires a two day process consisting of one overnight spin of at least 16 hours at
a speed of 90, 000g, then taking the fractions of interest and re-spinning overnight
in a new gradient [36]. This long processing time is undesirable because the
sample could be susceptible to degradation and the contents of the organelles
could have leaked. Furthermore, the current centrifugation technology does not
permit separation of the early endosomes from the late endosomes. Thus, it was
not considered as a candidate for subcellular fractionation.
1.2.2. Free Flow Electrophoresis (FFE)
Free Flow Electrophoresis (FFE) involves repeatedly streaming a thin film of the
sample dissolved in a fluid medium between two charged parallel electrode plates
for many hours [37-40]. The high voltage generates an electric field that deflects
the charged species in the sample towards one plate or another. According to the
manufacturer's website, FFE can segregate a variety of organelles including
endosomes, calciosomes, lysosomes, peroxisomes, melanosomes, vesicles, ER,
and mitochondria [41]. It has also been used in conjunction with DGC for the
isolation of endosomes [42, 43] as well as combined with an immune reaction for
the isolation of peroxisomes [44].
However, four main concerns make FFE an inappropriate research tool. At a cost
of $240,000 or greater, FFE is highly expensive. Like centrifugation, FFE also
requires lengthy run times and multiple runs are needed to get all the desired
fractions. Furthermore, current set ups often dilute collected sample considerably.
Lastly, FFE relies only on charge, and the gene vectors being tested have positive
charges that can affect the separation of the organelles [45].
1.2.3. Multi-step or Differential Centrifugation.
Differential centrifugation is a procedure in which the homogenate is subjected to
repeated centrifugations each time increasing the centrifugal force [46-50]. In the
Pol paper, at least six spins were involved with spin times varying from as little as
20 minutes to 170 minutes, and speeds going from 600 g to 104,000 g [51].
Differential centrifugation uses an equilibrium density gradient and can be used to
separate out nuclei, mitochondria, lysosomes, and microsomes. Sometimes a
homogenization solution is used to acquire the desired separation of homogenate.
It is a close cousin to the density gradient centrifugation, the only difference is the
multiple times and increasing centrifugal force. Thus, it has similar limitations in
the lengthiness of the process and insufficient resolution in separation. Also, for
both of these procedures, samples are often lost disproportionately between each
spin step and as a result it is very difficult to make accurate quantitative
measurements.
1.2.4. MEMS Separation Devices
MEMS separation devices have great potential for accurate and repeatable one
step separation. However, very little literature is available for using MEMS
separation devices for subcellular fractionation because this area of research is
relatively undeveloped. Consequently, using MEMS devices would require
significant design and development time in addition to characterization and
optimization to the desired cell types. The current MEMS devices must be greatly
modified to allow for easy sample recovery and accommodate enough material to
meet the sensitivity demands of quantitative assays in present day formats [45].
1.2.5. Density Gradient Electrophoresis (DGE)
The most preferred option is density gradient electrophoresis (DGE) which
incorporates both density and charge as a tool for separating the organelle
populations. A new separation device developed by Tulp allows for greater
resolution in separating endosomal and lysosomal membranes [30, 52-57]. Other
labs have developed variations from the Tulp prototype such as Lindner [58].
DGE utilizes a stationary phase of a neutral polymer such as Ficoll for separations
in a macro-scale channel. The polymer is distributed within a continuous linear
density gradient in the direction of separation within the channel. A voltage
gradient is also applied in the same direction as the density gradient, providing
two modes of discrimination.
DGE has successfully separated early endosomes, late endosomes, lysosomes,
golgi bodies, endoplasmic reticulum, and plasma membranes on Mel Juso cells
and Hela cells in preliminary studies [52-57]. The density gradient electrophoresis
device is also easier to set up and provides a much more affordable alternative for
multiple experiments. It also can handle cell numbers that provide enough
material to satisfy sensitivity limits for the required quantitative assays in their
current formats. It also involves a shorter length of time to accomplish a
successful organelle separation and as a result can allow for slightly higher
throughput sample processing than other currently existing methods [30].
1.3. Objective and Aims of the Thesis
The main goal is to modify Tulp's density gradient electrophoresis (DGE) device [52-57]
and develop a protocol for using it to separate the endosomal and lysosomal
compartments of rat hepatocytes. Primary hepatocytes are ideal for gene therapy and
drug delivery research because the liver is involved in processing most drugs that end up
in the bloodstream. Yet, there has been little research devoted to subcellular fractionation
of primary hepatocytes in the interest of studying endosomal uptake and trafficking. The
study will allow us to use DGE to better study and understand endosomal trafficking in
hepatocytes as well as develop a more descriptive quantitative model of gene delivery
through the entire cell.
Specific Aims
a. Modify DGE sample preparation protocol to attain optimal separation of early
endosomal, late endosomal, and lysosomal peaks in primary rat hepatocytes.
b. Demonstrate and verify organelle mapping via HRP and beta-hexosaminidase
assay peaks by performing western blotting on the collected DGE fractions.
c. Determine how DGE separation of a sample is affected by the addition of
positively charged PEI gene vectors and if needed, re-optimize protocol.
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2.0 Sample Preparation
It is important to process the cells and tissue samples prior to loading onto the density gradient
electrophoresis (DGE) device in order to extract the nuclear and cytoplasmic fractions for
analysis of vector and plasmid levels. The cytoplasmic fraction would represent vectors and
plasmids that have escaped from the endosomal pathway, whereas the nuclear fraction would
represent those that have translocated into the nucleus. Moreover, the DGE device depends on
separation of organelles by density and charge and is limited in space, so the sample loaded
should be free of large nuclei and charged cytoplasmic proteins that would disturb the migration
of the organelles.
Thus, the sample preparation consists of six general steps: (1) tissue culture, (2) cell collection,
(3) lysis, (4) the nuclear spin, (5) pre-endosomal spin processing such as trypsinization, and (6)
the endosomal spin, resulting in a condensed organelle pellet that can be re-suspended in the
desired Ficoll-70 concentration and layered into the DGE device. Between the first and second
steps is an optional gene delivery or pulse-chase-pulse step.
This chapter will first discuss important factors (Section 2.1) that were taken into consideration
when developing the protocol and then discuss methods of evaluating the protocol (Section 2.2).
Section 2.3 to 2.8 will detail various tests involved in developing the protocol in each of the six
major steps. The last section (Section 2.9) will discuss the optional pulse-chase-pulse step. The
gene delivery protocol will be addressed in chapter 6.
2.1. Considerations for Sample Preparation Protocol
In addition to removing the cytoplasmic and nuclear fractions from the sample prior to
loading, many other factors were taken into consideration in the development of the
sample preparation protocol. The amount of gene vectors in a particular organelle
population must remain constant throughout the entire sample preparation and density
gradient electrophoresis process because it needs to be a true representation of cell state
at the time of lysis, thus the cell trafficking must cease at exactly the desired time point
being tested and organelles need to remain intact.
2.1.1. Prevent cell trafficking
If cell trafficking occurred during sample preparation, the gene vectors could
travel to other organelles or cellular compartments and distort the representation
of the actual location of gene vectors at the desired time point. Thus, all steps
prior to cell lysis were done on ice with the exception of specified incubations at
370 C because endosomal movement stops at temperatures below 100 C.
2.1.2. Intact organelles.
The organelles need to remain intact so that the gene vectors and the contents of
the organelles do not leak. Thus, the process must be gentle enough not to
damage the organelles. Cell collection and lysis steps were often tested with cells
that were labeled with Hoechst DNA dye and the collected cells and lysates were
examined under a light microscope to see if the DNA was leaking out of the
nuclei. Nuclei are larger than organelles and easier to break during cell collection
and lysis. Past studies have shown that intact, unbroken nuclei would indicate
that the smaller organelles were unharmed [52-57].
2.2. Methods for Determining Optimal Method
A combination of imaging and assays was used to evaluate the success of specific
protocol variants. Imaging was primarily used to directly determine the condition of the
cells and organelles during cell culture, cell collection, and lysis, whereas the assays
demonstrated the degree to which the organelle populations were separated in the density
gradient electrophoresis device and indirectly, the quality of the sample.
2.2.1. Microscopy and Imaging
Imaging was performed on a Zeiss Axiovert 100 Microscope to assess the quality
of specific cell culture conditions and evaluate the quality of cell collection and
lysis. Images were recorded with Openlab 4.0.3.
a. Cellular Debris - The tissue culture plates containing the cells are examined
by microscopy for amount of cell debris. Large quantities of cell debris and
certain cell morphologies can indicate cell death, whether from seeding too
many cells, insufficient nutrients, contamination, de-differentiation,
detachment from collagen or other reasons. In cases of too much debris, the
dead cells and broken membranes may affect lysis, thus, cell culture conditions
were adjusted to limit cell debris.
b. Formation of bile ducts - Another indication of healthiness is the grouping
of the hepatocytes into islands of cells and the subsequent formation of bile
duct precursors in these islands of cells.
c. Cell Shape/Morphology - The tissue culture plates containing the cells are
also examined by microscopy for the cell morphology. Healthy cells are
cuboidal in nature, whereas cells that are spread out thinly on the plate are
usually starting to de-differentiate and lose hepatocyte phenotype.
d. Hoechst - The Hoechst dye is used to label DNA and nuclei. The Hoechst
dye is light sensitive and comes in liquid form. The plates are washed once in
PBS before labeling with the dye, diluted 1:1000 in Hepatocyte Growth
Medium (HGM) by incubating in 37°C for 10 minutes. The cells are examined
for leaky nuclei before cell collection, after cell collection, and after cell lysis.
e. Whole Cell/Nucleus Count - A small sample of the cell lysate (10 pl) is
examined in a hemacytometer to determine the quality of the lysis. The
number of whole cells and nuclei are counted in the four 4x4 sections. A good
lysis should have more than 95% nuclei or less than 5% whole cells.
2.2.2. Assays
Three assays were performed on the fractions collected from the DGE device. In
addition to showing successful separation of peaks, the assays also demonstrated
the repeatability of the experiments as the assay results were often similar from
one run to the next. This section gives an overview of purposes of the assays,
whereas the details of actual assays are covered in Appendix 3 and the results will
be covered in Chapter 4.
a. Beta-hexosaminidase (P-hex) Assay - The P-hex assay measures lysosomal
activity, specifically that of the beta-hexosaminidase enzyme, and therefore
indicates the location of the lysosomes.
b. Horseradish Peroxidase (HRP) Assay - The HRP assay indicates the
location of HRP. Normally, before performing this assay, the cells are pulsed
twice with HRP, one pulse of HRP will end up in the early endosomes and the
earlier pulse in the late endosomes. Thus, the HRP assay indicates the location
of the two endosomal populations of interest. Typically, the hepatocyte late
endosomes are labeled with a four minute pulse and an eighteen minute chase,
whereas the early endosomes are labeled with a three minute pulse. So
together it is a four minute pulse plus a fifteen minute chase plus a three
minute pulse of the HRP. The pulse-chase-pulse times vary from cell type to
cell type as the endosomal pathway dynamics vary by cell type.
c. Bicinchoninic acid (BCA) Assay - The BCA assay was used to measure total
protein levels. The idea behind the BCA Assay is similar to the Lowry
procedure, in that both rely upon the formation of a copper-protein compound
and then a reduction of the copper. However, it is preferable as it is more
sensitive in detection of protein levels and more applicable over a broad range
of protein concentrations. The BCA assay was used to determine the
concentration of proteins in the DGE fraction. It was found that the majority
of the proteins migrated with late endosomes and lysosomes, demonstrated by
the coinciding peaks in the BCA, HRP and P-hex assays. In addition to
determining relative protein levels throughout the DGE fractions, the BCA
assay was also used during the sample preparation process to determine the
total protein of the post-nuclear supernatant so that the appropriate amount of
trypsin could be added.
2.3. Tissue Culture Conditions
Tissue Culture conditions are quite important as they affect the cell function and
metabolism and how closely the in vitro experimental results can predict in vivo effects.
2.3.1. Collagen
The density gradient electrophoresis process was developed using Mel Juso cells,
a cell line derived from human melanoma. These small epithelial-like, adherent
cells are easy to culture, whereas hepatocytes require a large support structure of
other cells and proteins; thus hepatocytes are usually cultured in "collagen
sandwiches". Research has demonstrated that sandwiching isolated hepatocytes
between two layers of collagen extends the viability of the cells and preserves
liver-specific cell functions.
However, thick layers of collagen and extracellular matrix can hinder the
mechanical methods used to segregate and lyse the cells. Thus, the first step in
the development of the sample preparation protocol was to find the minimum
level of extracellular matrix or collagen that would be sufficient in maintaining
healthy hepatocytes for about 48 hours to 72 hours.
Figure 3. Collagen Culture Conditions
Hepatocytes were seeded on tissue-treated Petri dishes and on regular Petri dishes
both in the absence of collagen and in the presence of an adsorbed collagen
monolayer. The single collagen monolayer consisted of diluting collagen 1:100 in
Phosphate Buffer Solution (PBS) to a concentration of between 30 and 40 ýpg/mL
and incubating the solution on the Petri dish for two hours to let the collagen
settle onto the bottom of the Petri dish. The PBS is aspirated immediately prior to
seeding the cells. No significant difference was observed between tissue-treated
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and non-tissue treated Petri dishes without collagen; both were significantly worse
at maintaining hepatocyte viability compared to the collagen monolayer and
collagen sandwich. Hepatocytes began de-differentiating within two or three days
for the non-collagen plates.
Later, acting on a tip from another lab, the hepatocytes were seeded on dried
collagen monolayers. For the dried collagen, the PBS is aspirated two hours
before seeding the cells, and the collagen treated plates are left in the hood to dry
for those two hours. The dried collagen monolayers seemed to produce the best
results overall in cell viability on the plate and nuclei yield during the lysis.
2.3.2. Seeding Density
Three seeding densities (3 million, 4 million, and 5 million hepatocytes) were
tested on large 10 cm Petri dishes. Three plates for each condition were first
examined after 24 hours for cell viability, specifically evaluating the morphology
of the cells, the quantity of cell debris, and presence of bile ducts. 4 million
hepatocytes on the large 10 cm Petri dishes seemed to be the best option with a
cell confluence of approximately 90%, satisfactory levels of cell debris, and
presence of a few bile ducts. The 5 million seeding density was too high and
caused too much debris whereas the 3 million seeding density had satisfactory
levels of cell debris but less cell interaction and cuboidal cells, and more cell
spreading (data not shown).
After all this experimentation, we later changed to using 60 mm Petri dishes so
that not as much gene vectors and plasmid materials would be needed per gene
delivery run. Figure 4 shows the time course of the 2.5 million and 3 million
plates over the period of 3 days. Initially, the seeding density did not affect the
overall viability of the cells. After 24 hours, both conditions looked comparable,
although the plate with 3 million cells had slightly more cell debris. However, the
cells deteriorated dramatically over time and the differences between the two
conditions became more obvious. At 48 hours, the hepatocytes on one of the three
plates seeded at a concentration of 3 million began to demonstrate a loss of
adherence to the plate and increased spread and debris. The rest of the plates
showed a slight loss of structure. Then at 72 hours, both conditions demonstrated
greater spread, where boxy cells disintegrated into flat and amorphously shaped
cells. Also at 72 hours, another of the 3 million cell plates had large sections of
non-adherent cells. After 96 hours, all the cells had stopped adhering to the plates
for the 3 million cell plates and two of the 2.5 million cell plates (not shown).
2.5 million cells 3 million cells
Figure 4. Seeding Density and Incubation Time. The length and density of the
culture affects the hepatocyte viability. The 2.5 million cells at 24 hours look the
best.
These experiments demonstrated that it would be ideal to run gene delivery
experiments and density gradient electrophoresis on 24 hour hepatocytes to ensure
24 hr
48 hr
72 hr
that the liver cells are still healthy and not yet de-differentiated. Thus, the
protocol calls for culturing 75 thousand primary hepatocytes per cm2 on dried
collagen monolayer for 24 hours with a media change 4 hours after seeding to
select for healthy, adherent cells and to cut down on the amount of debris.
2.3.3. Incubation Time
The cell cultures were tested for viability over one, two and three days to
determine whether experiments could be performed on two or three day cultures.
Cells were examined 24 hours, 48 hours, and 72 hours post-seeding. Media was
changed 4 hours after seeding and after each 24 hour time point. Because the
hepatocytes were seeded on minimal extracellular materials - just the dried
collagen monolayer - cells became progressively worse in viability,
demonstrating increased cell debris which indicates cell death as well as increased
cell spreading and loss of normal hepatocyte morphology. It was concluded that
all experiments should be done within 24 hours post seeding.
2.4. Cell Collection
The process of cell collection is relatively simple. Its aim is to collect as many of the
cells as possible from the Petri dish into the centrifuge tube so that the quantity of cells
used is consistent from one experiment to the next and adequate material is provided for
sample processing and all downstream assays. Despite the simplicity of the concept of
scraping cells, our experiments have determined a method that is very successful in
obtaining a clean plate. This process is detailed in Section 2.4.4.
Please note that it is of great concern that subcellular trafficking does not continue during
the cell collection process so that the time points are accurate. Thus, all washes and
scraping are done on ice trays. The solutions and buffers are kept on ice during all
incubation steps to maintain their low temperatures. Furthermore, the centrifuge tubes
used for collecting the cells should be pre-chilled in the ice bucket.
2.4.1. Washes
Before cell scraping, the cells are cleansed of floating dead cells and other loose
debris with two washes of PBS++ and one wash of DGE buffer to prime the cells
:for collection in DGE buffer. The cells are collected in DGE buffer because the
hypotonicity of the solution causes cell swelling and enhances cell lysis. See
section 2.5.2 for more details.
2.4.2. Cell Scraping Methods
Originally, cells were scrapped with a large, reusable rubber scraper unit that
could be attached to the end of a 2 ml pipette. The rubber scraper was relatively
flexible or flimsy. Over the last year or more, cell scraping has been done with a
more rigid, disposable white scraper. Various methods of scraping were tested
and the plates were examined for leftover nuclei and whole cells as well as leaky
nuclei. The best way to retrieve the maximum number of cells is to take
advantage of the collagen matrix and try to scrape up all the cells in one smooth
and continuous scrape. The collagen will help hold together the cells and also
ensure a cleaner plate.
The best way to scrape the cells is to hold the Petri dish firmly on the ice with
your left hand and press firmly down on the plate with the white scraper with your
right hand. Use the left hand to smoothly rotate the plate counterclockwise while
the scraper makes 2 continuous clockwise rotations around the plate: the first with
the scraper firmly against the outside wall of the Petri dish, the second swoop in
the middle of the Petri dish to collect the unscraped cells in the middle. After the
first swoop, a distinct difference between the unscraped sections and scraped
sections should be obvious as the first is clear and the second is lightly opaque.
The scraper should now have a yellowish or orange band of cells stuck on. To
remove these cells and resuspend in the solution, tilt the plate towards so that the
DGE solution pools at one end of the plate, and gently dip the tip of the scraper
into the pool and shake it back and forth. The vibrations will cause the band(s) of
cells to loosen and come off. Keep shaking until the scraper no longer has specks
of yellow. Then pipette up the cells and the DGE solution into a pre-chilled
centrifuge tube (Coming)..
Figure 5. Cell Scraping Method (A) Scrape with one continuous motion, so all
the cells collect on the scraper. (B) Gently shake off the cells. (C) Secondary
scrape.
In order to ensure maximal collection of the cells on the plate, the plate is first
scraped in 2 ml of DGE and then re-scraped in 1 ml of DGE. The second
scraping technique involves (1) the circular swoop followed by (2) scraping
downwards multiple times while tilting the plate for maximum cell and DGE
solution collection. The first swoop cleans the outer border while the second set
of scraps covers the center portion of the dish. Rotate the dish and repeat a few
times. The cells and DGE solution are then pipetted into the same pre-chilled
centrifuge tube and incubated on ice. The tube is mixed gently so that no cell
clumps remain before the incubation.
2.4.3. Dispase
Dispase is commonly used in the lab to loosen and resuspend cells from tissue
culture. However, this process requires incubation at 370 C and thus would result
in continued endocytosis and trafficking during the cell collection process after
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the desired time point. Mechanical scraping and lysing allows greater control over
the time point and is sufficient for removing the cells and minimal collagen
monolayer.
2.4.4. Elimination of Whole Cell Spin
The original sample preparation protocol included a centrifuge step at 50 G to
spin down the whole cells in an effort to concentrate the cells and separate out and
discard cell debris and broken membranes. However, this step was eliminated
after noticing that the cell collection process actually lyses many cells and thus,
this whole cell spin would actually eliminate valuable nuclei and organelles as
well as cytoplasmic contents from the rest of the experiment. Because the whole
cell spin is eliminated, the two PBS and one DGE washes before cell collection
are very important in removing the cell debris and broken membranes.
Figure 6. Petri dish after Cell Collection.
No cells left on the plate after new
scraping protocol, but in the top right hand
corner, there is a nucleus (circled in
green), which indicates that the cell
collection step also lyses the cells.
2.5. Lysis Conditions
Lysis is an integral part of the sample preparation process as it breaks the cell into the
components that will be separated by centrifugation and electrophoresis. It is imperative
to achieve maximal lysis but without sacrificing the integrity of the organelle membranes.
If lysis is incomplete, the organelles cannot escape during the nuclear spin into the
supernatant, and the amount of the sample being tested will be diminished accordingly.
If the lysis is too rough, the organelles carrying molecules of interest, perhaps the gene
vectors, will rupture and these molecules will leak out. Then the levels of these
molecules such as gene vectors detected in the organelles will be an underestimate of the
actual number at the time of lysis. Thus, a large portion of the time spent designing the
sample preparation protocol experiments was focused on the lysis.
Lysis was measured by the ratio of nuclei to whole cells. Cells were dosed with Hoechst
Solution, a dye that localizes to the nucleus. The lysate was examined for under the
microscope for leaky nuclei, which would indicate that the lysis process was too rough
and was destroying the nuclei and organelles. If nuclei stayed intact, it could be safely
assumed that the smaller endosomal organelles were also intact.
2.5.1. Ideal Cell Concentration
Lysis was tested over a range of cell concentrations. First, lysis was tested on
direct dilutions of cell suspensions (750,000 cells; 600,000 cells; 500,000 cells;
375,000 cells; and 175,000 cells all in 1 ml of HGM). The ratio of nuclei to
whole cells increased as the cell concentration decreased, demonstrating an
inverse relation between cell concentration and success of lysis. The lysis at 500K
and 600K cells was a good balance between providing a good ratio of nuclei to
whole cells while providing enough nuclei and cell parts for experiment. This
later translated to a seeding density of 750,000 to 800,000 cells/ml because
invariably cells would die and be sloughed off during the overnight incubation
and the many washes, and the final density of the cells being lysed would be more
around 500 to 600K per milliliter.
Lysis was also done on tissue cultured cells. As described in Section 2.3.2, nine
10 cm Petri dishes were seeded, three at each of the three different seeding
densities (3 million, 4 million, and 5 million hepatocytes). The cells were first
examined and then the cells were scraped, collected, and lysed. The lysates were
then examined under the microscope for nuclei to whole cell yield. Higher
seeding densities proved to be a barrier to good lysis by syringe and needle. The
higher the seeding density, the greater the presence of whole cells. Again 4
million cells was a good compromise.
As described in Section 2.3.2, the tissue culturing was switched from using the
large 10 cm to the smaller 60 mm dishes to reduce the amount of materials, such
as the gene vectors tested or horseradish peroxidase, used per run. Seeding at
750K to 800K per milliliter at a total of 3 milliliters has consistently yielded
nuclei to whole cell ratios of over 95-99%. Usually the hemacytometer count
reveals approximately 250 nuclei to 2 or 3 whole cells.
2.5.2. Hypotonicity
To enhance the lysis yield of free nuclei, the cells were suspended in the
hypotonic DGE buffer and incubated for 5, 10 and 20 minutes to compare the
effects of the cell swelling. Incubations were done on ice to prevent further
endosomal trafficking. It was validated that increased incubation times enhanced
lysis. Due to the lengthiness of the density gradient electrophoresis process and a
desire to prevent as much subcellular trafficking beyond the time point as
possible, the protocol has established the 20 minute incubation time as the
standard.
2.5.3. Needle Size
Needle sizes were compared on the basis of both length and diameter, which is
also known as gauge. The lower the gauge, the greater the diameter. Over the
course of two experiments, the following needle sizes were tested: 18G1/2,
20G1/2, 21G2, 22G1/2, 23GI for nuclei yield of primary hepatocytes. 18G1/2,
20G1/2 and 22G1/2 were compared to see if the gauge or thickness affected the
lysis. It was hypothesized that the higher gauge would enhance lysis. All five
needle sizes were used to compare the effects of needle length. It was
hypothesized that a greater length would enhance lysis. It was determined that the
gauge had a greater effect than length and that 21 G2 was a good blend of both
factors. The greater the gauge also created greater resistance in the pumps which
help slow the mechanical lysis process to a more gentle pace upon ejection back
into the tube.
Later, similar tests were completed on the HepG2 cell line. Lysis of the HepG2's
varied less from condition to condition so 21 G2 was also chosen to keep the
experiments consistent.
2.5.4. Mechanical Lysis Strength, Frequency and Number.
During the lysis tests, the number of pumps and the speed at which the solution
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was pumped through the syringe was tested. The lysis had the
best results when the slanted tip opening of the needle is pressed
against the slanted edge of the centrifuge tube during the
expulsion part so 
the cells hit the 
centrifuge tube wall 
as it
leaves the syringe and at a gentle speed of seven to eight
oces nds for uptake and seven 
to eight seconds for expulsion 
of
the 3 ml of fluid. Often ten pumps were sufficient for a good
lysis yield of 95% nuclei but an additional two pumps were done when lysis was
incomplete. Thus, the protocol calls for twelve pumps to ensure complete lysis.
2.5.5. Conclusions.
The collected cells still suspended in the hyptonic DGE buffer were incubated on
ice for 20 minutes. Cells were further subjected to mechanical lysis with 12
gentle pumps of a 21G 2 inch needle (BD Precision Glide) and 3 ml syringe (BD
Luer-Lok Tip) to ensure a large ratio of nuclei to whole cells. The nuclei and
cells were counted using a hemacytometer to confirm that the percent of whole
cells to free nuclei was less than 5% and usually less than 1%.
2.6. The Nuclear Spin
Different speeds (30G, 40G, 50G, 100G, 150G, 300G, 1000G, 1100G, and 1200G) and
spin time lengths (3 min, 10 min, and 15 min) were tested. The speed and time should be
sufficient to spin down all the nuclei but not too high as to make the pellet to hard to re-
suspend. It was determined that 1100G and 15 minute was the best option so the cell
lysate was spun down (Brinkman Centrifuge 5804R) at 2500 rpm, which is
approximately 1125G, for 15 minutes at 40C to obtain the post nuclear supernatant (PNS)
and the nuclear pellet. The nuclear pellet was frozen for future studies.
2.7. Pre-endosomal Spin Processing
The supernatant from the nuclear spin must be processed before the endosomal spin by
adding trypsin and protease inhibitors. The trypsin enhances the later separation of
organelles by separating the organelles from their associated cytoskeletal filament
components and also provided differential cleavage of proteins on the different organelle
surfaces, whereas the protease inhibitors prevent further protein degradation to ensure
sample integrity for the remainder of the run.
2.7.1. BCA Assay.
The micro BCA protein assay (Pierce, Cat #: 0023235) is used to determine the
total protein amount in the post-nuclear supernatant, which contains the
cytoplasm and organelles of the cells. The total protein amount is needed to
calculate how much trypsin is needed. Typically, protein concentrations are
approximately 0.45 to 0.5 jlg/il so with a volume of 1.8 to 1.9 ml, the total
protein amount is typically near 0.8 to 1 mg. Loading too much total protein onto
the column (greater than 2 mg) can affect the consistency of separation, so for
larger samples only a fraction of the total samples should be processed for
organelle separation.
2.7.2. Trypsinization.
Trypsin is added to enhance the separation of the organelles by breaking some
protein-protein interactions and protein-membrane interactions to free organelles
from attachments to other parts of the cell. The amount of trypsin that should be
added depends on the total protein present in the sample. 25 Plg of trypsin (Type
12 A Bovine Pancreas) is need for each milligram of protein and at a
concentration of 1 jig/Al, this translates to 25 jll per mg of protein.
Trypsin works best at 370C so the post-nuclear supernatant (PNS) and the trypsin
aliquot should both be incubated in the water bath for one to two minutes prior to
adding the desired amount of trypsin. After adding the trypsin, the PNS sample is
incubated for an additional six minutes to allow the enzyme to function before
adding the trypsin inhibitor (4 jig of trypsin inhibitor for every 1 [tg trypsin
added). The trypsin inhibitor aliquots have concentrations that are four times the
concentration of the trypsin, so the same volume of trypsin inhibitor is added to
the trypsin and PNS. The trypsinized PNS is also put on ice to help the inhibitory
process.
2.7.3. Protease Inhibitors
The amount of protease inhibitors that should be added depends not on the protein
amount but on the final volume. The final concentration of the protease inhibitors
should be 2.5 jig/ml aprotinin, ImM PMSF, and 10 jtg/ml leupeptin. Because the
centrifuge tubes undergo so much pressure in the ultracentrifuge, the centrifuge
tubes need to be completely filled. Thus, the final volume is typically 8100 jl
which translates to 40.5 jl of PMSF, 8.1 jl of Aprotinin, and 16.2 [l of Leupeptin
for the stock concentrations of the aliquots described in the appendix. The PMSF
usually precipitates out of solution during the defrosting process so it needs to be
well mixed before adding. The PMSF is also quite strong, so PNS is first diluted
with about 5.5 ml of cold PBS before adding the protease inhibitors.
2.8. The Endosomal Spin
The endosomal spin requires a one hour long ultra high speed centrifugation in the
Beckman L8-70 M Ultracentrifuge. Because of the high speed, particular attention needs
to be paid to balancing the samples correctly. Furthermore, the temperature needs to be
at 4°C and the chamber must be vacuum sealed and with minimal pressure to prevent
friction and overheating.
Both the ultracentrifuge and the rotor need to be pre-cooled so that the run can occur at
the correct temperature of 4VC. Both take over an hour to reach 4VC and both
preparations are necessary, otherwise the chamber will be too warm and the sample will
have to sit and wait in the centrifuge for an additional half hour to forty-five minutes
while the centrifuge reaches the correct temperature.
2.8.1. Pre-cooling the Ultracentrifuge
The ultracentrifuge takes over an hour to reach the appropriate run temperature of
4°C. Thus, it needs to be pre-cooled at least an hour prior to use. To do so, turn
on the centrifuge by moving the switch to the ON position. Open the centrifuge
chamber to verify that the centrifuge is clean and empty. Replace the chamber
door and press VACUUM to initiate the depressurization inside the chamber.
Press TEMPERATURE and "4" and ENTER to set the temperature at 40 C. Both
the temperature and vacuum lights should be blinking. The vacuum helps the
temperature decrease more rapidly. Do not set the cooling temperature any lower
than 40C or the sample will freeze during the run. If the sample is frozen, the
organelles will be lysed by the ice crystals and be rendered useless for
experimental purposes.
2.8.2. Pre-chilling the Rotor
The rotor (Beckman Ti 70.1) itself also needs to be pre-chilled for about one to
two hours so that the samples and the entire centrifuge system are at 40C during
the spin. Do not pre-chill the rotor in the -20 0 C freezer as the rotor will become
too cold and freeze the sample. The rotor should be placed in the refrigerator or
in the cold room before beginning sample processing. As described above, if the
sample is frozen, the organelles will be lysed by the ice crystals and be rendered
useless for experimental purposes. If the rotor is not pre-chilled, it will warm the
pre-cooled centrifuge chamber and the run will be temperatures higher than 40 C.
2.8.3. Centrifuge Tubes
The lysate is transferred to a special polyallomer centrifuge tube (Beckman
Instruments, Optiseal) and additional cold PBS is added to make a final volume of
8.1 ml. The centrifuge tube should be pre-chilled on ice. The tube has a special
black plug cap and a gold rounded cap that has a hole on top. The hole enables
removal from the centrifuge post-spin. A threaded metal shaft can be screwed
into the cap and enable pulling the cap and centrifuge tube out of the centrifuge
rotor.
This tube with both caps on is weighed along with a balance tube with its own
two caps. The balance tube must be within 0.003 grams in weight. The volume of
the balance tube is adjusted by adding ice-cold water or PBS with a 200 ml
pipette. Because the density of water is 1 g/ml, if the balance tube is underweight
by 0.15 g, an addition of 150 pC of water should be sufficient to resolve the
difference. Typically, the balance tube can be re-used run after run and is stored
in the refrigerator to maintain its low temperature.
After the centrifuge tubes are balanced, they are inserted opposite one another e.g.
slot 1 and slot 7 within the pre-chilled rotor. The lid is replaced, and the handle is
screwed on to hold the lid in place.
2.8.4. The Run
To unlock the centrifuge door, press vacuum to start pressurization inside the
chamber. The temperature should start rising. When the door is unlocked, open it
gently and carefully place the rotor inside on the spindle and lightly spin the rotor
to make sure the rotor is settled. Replace the door and press vacuum to restart de-
pressurization. Set the temperature setting to 40 C, time to 60 minutes or 1 hour,
and speed to 40,000 rpm (translates to slightly greater than 100,000xG) by
pressing the corresponding button, typing in the correct number, and pressing
enter. When the pressure level is low enough so that the vacuum button stops
blinking, press display settings to reconfirm the settings and then if correct, press
start. The sample is spun down at 40C at 40,000 rpm for 1 hour.
2.8.5. After the Run
When the run is complete, press vacuum to start the re-pressurization and to
unlock the door. Then remove the rotor and use a paper towel to wipe dry the
inside of the centrifuge. Close the door and turn off the centrifuge by moving the
lever to the OFF setting. Don't turn off the centrifuge with the door open.
The supernatant should be decanted into a 15 ml eppendorf tube and labeled as
the Post Endosomal Supernatant (PES) and frozen for future experiments. The
organelle pellet is re-suspended in 650 pl of cold 6% Ficoll-70 in DGE buffer
with a 21G2-needle and syringe. Be even gentler with the syringe and needle
than during the lysis and flush the wall of the centrifuge tube with the 6% Ficoll
to coax the pellet off. When the pellet has fully come off the centrifuge tube wall,
transfer the solution into a pre-chilled 1.5 ml eppendorf tube and continue re-
suspending with the syringe. Then spin at 2,500 rpm in the small table top tube
centrifuge for fifteen to twenty seconds to eliminate the non-soluble pellet. This
6% Ficoll-70-organellar suspension is now ready to be loaded into the DGE
device.
2.9. Horseradish Peroxidase Labeling
The early and late endosomes are labeled with a pulse-chase-pulse of horseradish
peroxidase. The 24 hour plated hepatocytes were washed once with 3 ml cold PBS++ on
an ice tray in the fume hood. They were then incubated at 370 C in 1.5 ml of HRP labeled
medium (2 mg/ml HRP in HGM) for 4 minutes. The cells were then washed once with 3
ml cold PBS++ on the ice tray in the fume hood and incubated at 370 C with 3 ml of
unlabeled HGM for 15 minutes to chase this first pulse into the late endosomes. The cells
were once again washed with 3 ml cold PBS++ on a tray of ice and then incubated at
370 C with 1.5 ml of HRP labeled medium for 3 minutes. This second pulse will end up
in the early endosomes. Finally, the hepatocytes were washed twice with 3 ml cold
PBS++ and once with 3 ml chilled DGE buffer before cell scraping and collection.
The time points for the HRP pulses and chases were derived from Tulp's experiments
[52-57], which suggested a 25 minute chase time for Mel Juso cells. However, the 25
minutes proved too long for the liver hepatocytes. The late endosomal peak was
decimated because with the extra 10 minutes of trafficking, much of the HRP was
degraded by lysosomes. Thus, the chase time was adjusted to 15 minutes, and the late
endosomal peak in the HRP assay was restored
All washes and media changes were done on ice to prevent extraneous endosomal
movement and endocytic progression. The cold PBS++ is also meant to help stop
extraneous endosomal movement, while the added ionic content compared to stock PBS
helps maintain cell adhesion during the frequent washing and changing of medium. If
HRP labeling was not required, the plated 24 hour hepatocytes were washed twice with 3
ml PBS++ and once with 3 ml chilled DGE buffer before cell scraping and collection.
2.10. Results and Conclusions
The result of the above modifications to the sample preparation process lead to the
development of the protocol described in Appendix 5. These modifications have allowed
the DGE device to be used on primary hepatocytes, which are quite unlike the Mel Juso
cells with which an earlier version of the DGE device was first developed and
characterized. This protocol is affirmed by the results of the simple assays described in
Section 2.1.2 and Section 4.1 which demonstrate that the late and early endosomal
populations are separate and distinct. The results are explained in greater detail in
Chapter 4 because the modifications to the DGE setup and run described in Chapter 3
also affect the separation patterns, and thus these results come afterwards.
3.0 The Density Gradient Electrophoresis Device
The purpose of this chapter is to elucidate the finer points of the DGE protocol to help others use
this device. The first two sections describe the parts of the DGE device and its peripherals.
Then, the chapter highlights details in setting up the device and using the device that are
necessary for maintaining the integrity of the separation.
3.1. Parts of the DGE Device
The DGE device is similar in design to the Tulp lab DGE prototype as shown in Figure 7.
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Figure 7: The Parts of the DGE Device and Gradient Mixer. Schematic represents a
cross section of the device [54].
3.1.1. Body
The separation column (s) and the upper (I) and lower (II) electrophoresis buffer
chambers are machined from the same cylinder of polymethylmethacrylate
(PMMA). PMMA is easy to machine and has low affinity for protein adsorption
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and thus will not interfere with the separation the proteins and organelles. The
two inlets that lead to the upper chamber (1.1 and F) are used to fill the upper
chamber with DGE buffer and are connected to a peristaltic pump that
continuously cycles fresh electrophoresis buffer through the upper chamber.
Tubes that recycle the electrophoresis buffer for the lower chamber are inserted
into two inlets (II.1) that go directly to the lower chamber from the top of the
device.
An additional specially designed inlet (i) goes directly into the separation column.
This inlet is connected via tubing and a T-shaped connector to both a rubber
disposal tube and an electronically controlled syringe pump full of 10% Ficoll.
The first allows the contents of the separation column to slowly exit the column
with little disturbance to the relative positions of the column contents. The
second allows more 10% Ficoll, the separation medium, to be pumped slowly into
the separation column also with little disturbance to the relative positions of the
column contents. The two in conjunction allow the user to adjust the levels of the
column contents during the gradient loading and sample loading phases.
3.1.2. Electrodes and Associated Parts
Also made from PMMA are the removable electrode holders: the base of the
chamber (B) which holds the palladium cathode (P) and the top (n) which holds
the platinum anode (Pt). The two circular electrodes will have the same diameter
as the inner diameter of the cylindrical separation chamber to ensure constant
current density throughout the column. A non-gassing palladium electrode is
required because bubbles generated by a gassing electrode would cause
hydrodynamic disturbances to the contents of the separation column. Standard
banana clips attach the electrodes to both a commercial power supply box which
will power the device at 300 volts at constant current conditions at 10
milliamperes and a multimeter that confirms that the current being delivered is at
10 milliamperes during the entirety of the run. A potential applied under constant
current conditions is necessary to maintain a constant electromigration velocity
and important in making the high-resolution separations more pronounced
between different cohorts and more repeatable from run to run.
3.1.3. The Membrane
The contents of the separation chamber and the electrophoresis buffer of the lower
chamber are separated by a cellophane membrane (m) that is pre-wetted and cut
into a circle prior to being attached to the bottom of the separation chamber with
an O-ring (o). The cellophane membrane is permeable to both cations and anions
unlike the membranes used in the Tulp device, which were only anion-permeable.
Thus, the effect of water co-migration into the separation chamber is not a
concern and larger gradients and longer run times can be utilized as a result.
3.1.4. The Cone and Attachments
The top of the separation chamber has threads that allow a removable cone (c) to
be screwed into place. This is a specially designed cone that permits "precise
gradient introduction, thin sample layering (0.3-1 mm) and precise fractionation
after electrophoresis" [52]. The sample is directly pipetted into the top of this
cone whereas the sample collection requires that the cone is connected to a long
thin tube. The layering of the gradients requires a special gradient mixer
apparatus to be attached to the cone with a small rubber tube (v). The cone can
be seen in the upper right of Figure 8.
3.1.5. The Gradient Mixer
The gradient mixer is made from two PMMA columns connected by a rubber tube
(m) and a base piece. The column that connects directly to the cone is frequently
referred to as the "left leg" and has a groove at its base for the insertion of a
mixing rod (r). The left leg is typically filled with the more concentrated solution
to be mixed whereas the right leg is typically filled with the more diluted solution.
The mixing rod is attached to a simple motor which has a variable voltage (3 to 12
volts, 800 mA) AC adapter from Radioshack. The available settings are 3, 4.5, 6,
7.5, 9, and 12 volts. Keep the voltage at 6 volts during all gradient layering steps.
3.1.6. Clamps
Two main types of clamps are used in the density gradient electrophoresis
protocol. One is a C-shaped clamp with a screw that allows a continuous range
of widths. It is used to modulate the motion of fluid through the drainage tube.
The other is a scissor clamp that allows quick on and off clamping. This clamp is
used in a variety of locations to stop fluid motion through the tubes temporarily,
often used while filling a particular tube or compartment.
Figure 8. Picture of Clamps and Additional Parts
3.1.7. Additional Parts
Additional parts include a flat sieve, the stand, a large PMMA arm to guide the
thin collection tube, an additional PMMA piece to secure both the top electrode
and the gradient mixer to the top of the DGE device, and the screw that secures
the PMMA piece. The flat sieve is placed on top of the separation column when
filling the upper chamber with DGE buffer to minimize hydrodynamic
disturbances to the top of the separation column. The entire DGE device sits on
the stand which allows enough room to attach banana clips to the palladium
electrode at the bottom.
3.2. Peripherals
Peripheral devices as shown in Figure 9 are required for the DGE run. They are
explained in this section.
3.2.1. Vibration Isolation Table
The vibration isolation table (in white) is a 2210 Benchmate Vibraplane and is
made by Kinetic Systems (model # 2210-01-11, serial #128-1436). Prior to every
run, the system needs to be pumped with more air using a bicycle pump. Then it
needs to be leveled, using the little buttons that allow air to be released from the
three legs of the table.
3.2.2. Waste Beaker
The waste beaker can be seen sitting on the brown box at the lower left of Figure
9. It is where all the droplets are released so that level inside the separation
chamber can be modulated and lowered.
3.2.3. Power Source and Multimeter
The Power Source is the typical BioRad PowerPac (top right) and is used to
power the electrophoresis at constant current of 11 mA, which attains an actual
constant current closer to the 10.6 amps that the previous device ran at. The
yellowish orange colored Fluke 73VI multimeter was purchased from Radioshack
and measures the current output to make sure it remains constant throughout the
entire run.
3.2.4. The Perfusion Pump
The Perfusion Pump is labeled with a bright blue laboratory tape between the
isolation table and the Harvard Apparatus controller. It is used to circulate fresh
DGE buffer in the chambers. It is the same type of pump used for the liver
bioreactors in the lab and was constructed in the lab. It consists of simple digital
potentiometers that adjust the rotation speed of the pumping mechanism and thus
the flow rate of the solution through the tubes. The Silastic Brand Laboratory
Tubing is made by Dow Coming.
Figure 9. The Entire DGE Device Setup. [26]
3.2.5. The Ficoll Pump.
The pump that pushes Ficoll into separation column via the T-shaped tubing is
controlled by an electronic device from Harvard Apparatus (the big black box on
the right in Figure 9). The pump (far left) holds the syringe body, while a
moving piece presses on the depressor of the syringe. The moving piece is
controlled by the rotation of a threaded rod. The Harvard Apparatus controller
can be adjusted for different infuse and refill rates, although the device only
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pushes on the depressor and cannot pull to refill the syringe.
3.3. Modifications
The DGE device used for this thesis has an increased separation column length which
allows for greater separation. The Tulp prototype has a separation column of 7 cm in
length, whereas the new device displayed above has a separation column of 12 cm. The
buffer chambers, outlet and inlet sizes and flow rates were adjusted to compensate for
this increased column length. The gradient mixer and mixing motor are also larger
compared to the original Tulp design so that it can accommodate larger volumes to
provide a longer gradient.
Other changes made to the Tulp prototype when designing the current device include
cutting large wedges out the flat circular platinum electrode holder to enable wiping 02
and H2 bubbles produced during the electrophoresis process.
3.4. Buffers and Solutions
This section explains the role of the DGE buffer and Ficoll-70, the basis of the separation
medium.
3.4.1. DGE Buffer
The DGE Buffer is referred to as the homogenization buffer in all the Tulp Papers
[52-57]. It consists of 10 mM triethanolamine, 10 mM acetic acid, 1mM EDTA,
and 0.25 M sucrose. The pH of the solution is 7.4, which is in the range of
standard biological pH. The homogenization DGE buffer is relatively hypotonic
and helps the mechanical lysis of the whole cells. The presence of the sucrose is
to buffer the sugar column which used to be composed of sucrose in some of the
older Tulp experiments.
3.4.2. Ficoll-70
Many small molecules including sucrose and salts such as CsCl and NaBr are
osmotically active, so cells will in take these solutes and actually migrate to a
density that is not representative of its actual physiological character. Thus, many
current density gradient separation devices use polymer sugar solutions, iodinated
components, or colloidal silica. Sugar solutions with high molecular weights such
as Ficoll [59], a synthetic sucrose polymer or dextran [60], a natural glucose
polymer have been successful in separating membranous vesicles but dextran is
inconveniently viscous. Thus, Ficoll is the separation medium of choice.
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Figure 10. Ficoll Polymer
Ficoll has better osmotic properties than sucrose - it preserves functional and
morphological integrity and does not penetrate biological membranes. Previous
work [52-57] has demonstrated that Ficoll-70 works better than Ficoll-400.
3.5. Considerations in Setting up the Device
While the protocol is fairly specific in guiding the setup of the device, this section details
some additional tips and explains why certain details are necessary.
3.5.1. General Set up
The entire density gradient electrophoresis process is done in the cold room to
maintain the density gradient integrity and sample band uniformity by inhibiting
thermal fluctuations and to ward off temperature fluctuations caused by the
current powering the electrophoresis. Furthermore, the density gradient
electrophoresis device is set up on a vibration isolation table to minimize
disturbances to the contents of the separation column from vibrations caused by
movement in the cold room which is frequented by other members of the lab.
Prior to setting up the device, the vibration isolation table is calibrated so that the
top surface is level.
3.5.2. Assembling the Device
After leveling the table, the DGE device is assembled as specified by Tulp 12,'13
and according to Appendix 6. The device body must be briefly rinsed in MilliQ
or de-ionized water and dried with KimWipes prior to assembly. The cellophane
membrane (diameter approximately 7-8 cm) needs to be soaked in de-ionized
water until soft and then secured over the bottom opening of the inner column
with an O ring to create a semi-permeable barrier between the inner and outer
chambers. The membrane needs to remain wet at all times, even between runs;
otherwise it needs to be replaced. It is also important to test that the membrane is
providing a secure barrier before each run, by filling the separation column with
water and checking for leaks.
Next, the bottom piece with the palladium anode must be secured to the main
device body. Because the two pieces fit tightly, the screw-liked threads of both
the main device body and the bottom piece need to be well oiled with Vaseline to
allow the bottom piece to screw onto the main device body fully. Then, the entire
device is placed onto its stand on the vibration isolation table in the cold room.
All the rest of the steps with the exception of cleaning the gradient mixer are
performed in the cold room.
3.5.3. The Anode
The anode electrode must be connected to the power source prior to filling the
separation column, because the electrode is a bit hard to reach and connecting it
later will disturb the contents of the separation column.
3.5.4. The Syringe and T-shaped Tube
The next step is preparing to fill the separation column with 10% Ficoll which is
the base separation medium. A 60 ml syringe is first filled with 10% syringe. Fill
the syringe carefully to prevent bubbles. If there are any bubbles, make sure that
they are expelled because if they end up in the separation chamber, they will
disrupt the integrity of the separation.
Then the filled syringe is connected to longest arm of the T shaped tubing. The
shortest arm is clamped with a scissor-styled clamp, while the end of third arm is
put into the 10% Ficoll solution so that the syringe and the tubing can be filled
with the Ficoll. To do so, expel the contents of the syringe just until both arms
are filled and then re-fill the syringe. After filling both the syringe and two of the
arms with Ficoll, the third arm is clamped with the C clamp about half way up the
tube. The shortest arm is then unclamped and the T shaped tubing connector need
so be flicked so that any bubbles in the connector can escape. Then depress
syringe so that the short third arm is filled 80% before connecting to the DGE
device at inlet "i", the one that leads directly into the separation chamber.
Depress the syringe slowly until the membrane is covered by about 2-3 ml of 10%
Ficoll. Then secure the syringe in the electronic pump.
Then fill the lower outer chamber with DGE buffer through inlets II.1 and slowly
and carefully fill the separation chamber with 10% Ficoll with a 25 ml pipette,
pointing the tip at the wall of the separation chamber.
3.6. Filling the Separation Chamber
For these experiments, the sample was suspended in 6% Ficoll, so it needed to be layered
in between two gradients. The first, the lower gradient, is from 10% to 7%, and the
second, the upper gradient, is from 5% to 0% Ficoll. The lower gradient should be made
just prior to loading the sample so that the gradient has less chance of being disturbed,
just as the upper gradient should be layered right after the sample is put in. This way the
gradients can stay true to form as much as possible during the experiment.
3.6.1. The Lower Gradient
Grease the threads at the lip of the top cone and carefully screw on the cone to the
top of the separation chamber. Carefully attach the gradient mixer to the top cone
via the small rubber piece. Make sure there are no kinks in the connecting tubing
so that the solution in the gradient mixer will travel smoothly down into the
column. Secure the gradient mixer with the PMMA piece and metal screw. After
the gradient mixer is secured, slowly infuse the 10% Ficoll into the top cone and
into the tubing of the gradient mixer until it is just below the floor of the mixing
chamber, using the electronic pump. The speed should be no more than 3 ml/min.
The lower gradient is typically 6.5 ml in volume. The right leg should be filled
first with 3.5 of 7% Ficoll carefully with the pipette on the slow setting, letting the
solution drip down the wall to the bottom of the right column. Meanwhile, use
the scissor clamp on the tube connecting the two columns of the gradient mixer to
stop the flow of the 7% Ficoll from going into the left leg. It should just fill the
connecting tube. If any 7% Ficoll does enter the left leg, transfer it back to the
right leg with a thin pipette.
Then fill the left leg, the one with the outlet connecting directly to the separation
chamber, with 3 ml of 10% Ficoll. Make sure there are no bubbles. Then slowly
insert the stirrer into its groove and make sure it fits tightly. There is a metal
protrusion on the stirrer that should also fit a groove at the top of the left leg to
lock the motor and mixer place in place and make sure that the rotation is limited
only to the stirrer.
Set the power source at 6 volts and plug into the motor. Immediately loosen the
scissor clamp connecting the two legs to let the two differing Ficoll
concentrations start mixing. Next, loosen the C clamp to let the contents of the
separation column start dripping out into the empty Erlenmeyer flask. This is a
very crucial step as loosening the metal clamp too quickly will allow too high a
flow rate and mess up the gradient. So slowly allow the dripping to begin at an
approximate rate of 1 drop per second. Adjust the clamp periodically to maintain
a steady flow rate. The contents of the separation column will flow down while
the void created by this drippage will be replaced by the contents of the gradient
mixer. Stop the dripping by tightening the C clamp when the level of the solution
inside is about one third of the way down the cone.
Then slowly disconnect the stirrer and loosen the PMMA holder to carefully free
the gradient mixer by balancing on two of the three legs of the gradient mixer and
slowly lifting at an angle, making sure not to jar the DGE device.
Another very important step is to put a warning sign on the door to the cold room
at this point. The warning sign should ask people to note that a vibration sensitive
experiment is going on and they should be very slow and careful when opening
and closing the door.
The gradient mixer and stirrer bar should be washed with de-ionized water and
then dried KimWipes and compressed air.
3.6.2. The Sample
The sample should be already suspended in 650 jtl of 6% Ficoll as according to
Section 2.8.5. Only 500 il of this sample will be used for the DGE run and the
rest will be used for additional experiments later.
Take up 500 [ld using the P 1000 micropipette and with your free hand, gently and
slowly squeeze the shortest arm of the T tubing so that the contents of the entire
separation column slowly rise until about 1 mm to the tip of the cone top. Slowly
pipette in the sample into the tip of the cone top while slowly releasing the short
arm of the T-tubing so that the rate of addition and the downward flow of the
contents of the separation column are matched until all of the sample is pipetted
into the cone. Now the device is ready for layering the upper gradient on top of
the sample. If the level of the sample is flush with the top of the cone, loosen the
C-shaped clamp and let a few drops out so that the sample is about 1 mm below
the top opening of the cone. This is to protect the sample from somehow spilling
out or being flicked out while attaching the gradient mixer.
3.6.3. The Upper Gradient
Layering the upper gradient is very similar to layering the lower gradient except
for a few things that will be mentioned below.
Because the DGE device now contains the sample and the lower gradient, even
more care needs to be taken as not to disturb the relative positions of the contents
of the separation column during this and subsequent steps.
a. Make sure there are no ripples in the rubber connector between the gradient
mixer and the top cone.
b. The infusion rate of the pump should be adjusted to 2 ml/min.
c. The drip rate should be 1 drop per second. It is imperative that the drip rate is
eased into frequency and that the tube is not opened to quickly. If the sample
moves down the separation column too quickly when layering the top gradient,
the sample band will have a donut hole and sometimes, even worse, an atomic
bomb-like mushroom.
a. When filling the left leg, pipette very slowly and smoothly so that vibrations
do not bring the sample up from the connector into the left leg.
Much of the pertinent separation occurs in the upper gradient, so it is much longer
than the lower gradient. The right leg should be filled with 13 ml of DGE buffer
(equivalent to 0% Ficoll) and the left leg should be filled with 12.5 ml of 5%
Ficoll. Remember to use the scissor clamp while loading the two solutions, but
remove immediately after turning on the power source and before you start the
dripping.
The sample should appear as one flat whitish disc. If you get a donut or
mushroom, the run is essentially bad and the results unreliable, so perform these
steps very carefully. The sample is most vulnerable to being distorted while it's
traveling from through the cone shaped top and also transitioning from the cone
top into the separation column.
Continue dripping until the level of the entire gradient is clearly below the cone.
Disconnect the power source and loosen the PMMA holder and free the gradient
mixer. Then slowly unscrew the cone while holding the device making sure it
does not move
3.7. .Starting the Run
The successful segregation of the organelles is very sensitive to vibrations and other
disturbances as shown in some of the figures in Chapter 4. Special care needs to be taken
as not to disturb these contents. Like the previous two sections, this one will explain the
intricacies of particular details in the protocol and explain some of the reasons for these
precautions.
3.7.1. The Upper Chamber
Before starting the run, the top chamber needs to be filled with DGE buffer as
well. To minimize disturbances to the separation column, a metal sieve placed on
top of the column and the syringe pump infuses 10% Ficoll from the bottom until
the metal sieve is just fully wetted. The syringe pump should still be at an infusion
rate of 2 ml/min.
Then using one or two of the large 60 ml syringes connected to the tubes,
carefully fill the upper chamber with DGE buffer until it reaches the bottom of the
horizontal outlet. Slow down the filling rate when the water level approaches the
sieve and begins to cover it. The faster filling rate can resume after the DGE
buffer level is about 1 cm above the top of the sieve.
3.7.2. The Cathode
After the top chamber is filled, slowly remove the metal sieve. Then connect the
platinum cathode to the power source and slowly pivot the upper electrode into
place and secure with the PMMA holder. Be very careful not to move the device
or cause its contents to shift.
3.7.4. Buffer Recycling Pumps
The perfusion pumps used to circulate the DGE buffer in the lower chamber
should be turned on now, just prior to starting the run. The tubes that connect the
fresh DGE to the perfusion pumps and to the lower chambers should have already
been inserted into the lower chambers during the device set up step. Make sure
that approximately 400 to 500 ml of fresh (unused) DGE buffer is put into the
recycling beaker and be careful that there are no bubbles in the pump tubes
because bubbles that float up in the outer chamber during the run may cause
interference in the electric field.
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Figure 11. Current in DGE Device. The current delivered through the run stays
constant with very little drift throughout the run. [26]
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3.8. Run
The current is set at 11 mA and the device is run for 80 minutes at constant current mode
in the cold room (temperature 4QC). The current should be monitored every ten minutes
with the ammeter to make sure the current is approximately 10 to 11 mA. The positively
charged top electrode should be wiped every ten minutes to eliminate the build up of
resistance from the bubbles generated to maintain a constant current through the entire
separation process.
3.9. Post Run
The post run steps are relatively straightforward unlike the sample and gradient layering
details and the protocol covers most of the details, so this section will be relatively brief.
3.9.1. Removing the Metal Sieve
After draining the upper buffer column, it is important to let out a few drops from
the separation column so that the level of the solution drops below that of the
metal sieve. Otherwise, when the metal sieve is removed, droplets that roll down
the metal sieve may disturb the contents inside the separation chamber.
3.9.2. Setup for Fraction Collection
A very thin tube is used for fraction collection so that the droplet sizes are
smaller. The tubing should be approximately 10 to 12 inches long initially and is
trimmed after it is attached and threaded through the hole in the long PMMA arm
that replaces the electrode holder. It is also highly suggested that the tubing be
attached to the top cone (shoved inside) prior to screwing on the top cone to the
separation chamber. Remember to lightly grease the threads of the top cone.
It is also easier to place the collection plate on top of a box that is approximately
four fifths the height of the device during collection and just shift the plate when
needed.
3.9.3. Fractions
Initially, 10 to 11 drops of the inner column were collected in each 380 ld well of
a 96-well plate. To fill the well, 11 drops were initially required. As fraction
collection continued, drop size was observed to increase so 10 drops was only
needed. However, due to surface tension, the wells could hold up to eleven of the
larger drops by creating a bubble over the well. About 88 to 96 wells were filled
for the early experiments. Assays demonstrated that both endosomal peaks were
within the first 88 fractions.
Later, 24 fractions were collected in deep 96-well plates that can hold up to 1.25
ml, so that more sample volume was available for analysis. For example, the
Real-time-PCR requires at least 400 [ld of each sample. Although this change
meant that the different organelles were separated less than before, this number of
fractions and this volume of fractions was still sufficient enough to keep the
organelles of interest, the early and late endosomes populations distinct. Assays
demonstrated both endosomal peaks were within these 24 fractions and were
distinct and separate. The switch to twenty four fractions is only for the purpose
of assays like Western Blotting and PCR. A switch back to ninety-six fractions of
300 jl or even more fractions at an even smaller volume is certainly possible.
3.9.4. Infusion Rate
Initially, infuse at a rate of 2 ml/min to fill the cone and tubing, then the flow rate
can be switched to 3 mL/min. It is imperative that the infusion rate is at most 2
ml/min while the solution is rising through the cone and tubing because at higher
rates, the sample can be subjected to churning while transitioning from the
separation chamber into the cone and then into the tubing.
3.9.5. Storage of Fractions
The DGE Fractions should be temporarily stored at 40C to maintain the integrity
of the membranes. Once the HRP and beta-hexosaminidase assays are complete
or dialysis and ultracentrifugation is done, then the fractions can be frozen in the -
20 0 C. Freezing is also a form of lysis as the ice crystals will puncture the
membranes, so sample should definitely be frozen prior to Western Blotting.
3.9.6. Reversing the Current
It is important to reverse the current for the same amount of time as the run, to
recharge the palladium electrode. The current can be reversed in bulk after every
two or three runs.
3.10. Cleaning and Storage
Between runs on consecutive days, the device can remain in the cold room with the
separation chamber filled with 10% Ficoll and the outer lower chamber filled with DGE
buffer. After fraction collection, at least another 6 to 8 ml of separation chamber contents
should be infused out into the waste collection flask to ensure that the separation chamber
contains only 10% Ficoll.
If the device is not being used the next day, but the membrane is still intact, the device
should be rinsed with MilliQ water. It should then be stored in a light soap solution such
as Alconox and water. Make sure the membrane does not dry out.
4.0 Simple Analysis of Fractions
Simple assays were performed on the fractions to demonstrate the localization of the organelles
of interest as according to the Tulp papers. As demonstrated in this figure from Tulp et al. 1997
[55], the HRP assay has three humps: the first one at fractions 12 to 16 is the late endosomes, the
second larger one at fractions 36 to 40 is the early endosomes, and the third tiny hump at the end
near fraction 80 is for soluble HRP that escaped the endosomes. The lysosomal marker, beta-
hexosaminidase had two peaks, one at fraction 20 and a smaller one other at fraction. The figure
was modified so that the line demonstrating the data from the HRP assay has red dots, whereas
the line depicting the results from the beta-hexosaminidase assay has blue dots. According to the
paper, the fraction sizes were 0.25 ml and prior to electrophoresis, endocytosed HRP was used to
label the endosomal compartments and [125I] Transferrin to label the recycling vesicles and early
endosomes.
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Figure 12. DGE Separation of Organelles from Tulp et al. 1997 LE = Late Endosomes, L =
Lysosomes, RV = Recycling Vesicles, EE = Early Endosomes, PM = Plasma Membrane, s-Tf =
soluble transferrin, s-HRP = soluble HRP. [55]
The HRP, BCA, and 13-hexosaminidase assays demonstrated the success in modifying the
protocols for use of the DGE device with primary rat hepatocytes. The efforts described in
Chapters 2 and 3 allowed the DGE device to be used on liver cells and demonstrate repeatability
and greater precision in endosome localization than ever before. The results also demonstrate
the sensitivity of the DGE device to aberrations, emphasizing the care required when preparing
the sample and during the run.
4.1. Preliminary Data
The two graphs in this subsection represent initial tests performed on the new larger DGE
device right after it was constructed. Both experiments were done prior to modifying the
sample preparation and DGE protocols. Figure 13 shows the assay results of DGE on
Mel Juso cells on the new device. It can be compared to Figure 12 from the Tulp 1997
paper to demonstrate that the new DGE device is just as effective as the old Tulp
prototype and that the longer separation column did not reduce the effects of the electric
field. In fact, the separation of the endosomes was slightly increased with the late
endosomes shifted forward to a peak at fractions 6 to 12 and the early endosomes shifted
back to fractions 38-42. The beta-hexosaminidase activity appears to peak at fraction 19
similar to before.
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Figure 13. DGE of Mel Juso cells. Segregation performed on new device prior to
optimization of sample preparation and DGE protocols. [26]
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Figure 14. DGE of HepG2 cells. Segregation performed on new device prior to
optimization of sample preparation and DGE protocols. [26]
Figure 14 differs from Figure 13 in that this run was performed on HepG2 cells, which
are much more hepatocyte-like. Notice that the HRP does not have two peaks like the
previous figure. Instead levels just remained high from fraction 13 to about fraction 39.
This figure demonstrated the huge need to modify the protocols, particularly the sample
preparation steps to achieve good organelle separation of hepatocytes.
4.2. Protocol Modifications Improve Segregation
As described in Appendix 7, the DGE runs performed through the course of the thesis
project could be categorized chronologically into four sets. The first set, the early DGE
runs in the Spring and Summer of 2004, was for practice and also for assessing the
effects of many variations on the protocol such as testing the length of culture time or
comparing wet versus dry collagen monolayers. After over a semester and half a
summer of testing and modifying lysis methods, spin settings, and cell culture conditions,
the DGE separation results began to improve as shown in Figure 15.
1~ AA
100
Co
A
0
E2
E
4-
0 10 20 30 40 S9 60 70 80 90
Fraction Number (380 IPL)
Figure 15. HRP and P-Hex Assays from 7/8/04 DGE Run. The assay demonstrates
successful separation of late and early endosomal fractions. [26]
As shown in Figure 15, the modifications described in chapter 3 and 4 were successful in
improving the localization of late and early endosomes. Analysis of the eighty-six
fractions collected from a DGE run on July 8, 2004 revealed two distinct endosomal
peaks, the first representing the late endosomes and the second representing the early
endosomes. The horseradish peroxidase assay showed that early endosomes localized to
fractions 68 to 72, whereas the late endosomes peaked at fractions 41 to 45. The
lysosomal peak was found to be shifted approximately six fractions from the late
endosomal peak fractions. The secondary lysosomal peak was eliminated although there
is a shoulder that coincides with the late endosomes perhaps demonstrating some beta-
hexosaminidase activity in some of the late endosomes or maturation of a lysosomal
subpopulation.
These results demonstrated an early success in modifying the sample preparation and
DGE protocol from use on Mel Juso cells to primary hepatocytes. Notice that the relative
enzymatic activity in the fractions before, between, and after the two endosomal peaks
are essentially close to zero (less than 5% of the maximal activity) demonstrating
successful separation of the two organelle populations and an increase in precision of
organelle localization. Furthermore, the peaks are well centered on the graph,
demonstrating the fraction number is appropriate for the fraction volume collected, and
that the gradient length and distribution is also optimal.
4.3. Causes of Noise and Abnormal Peaks
Other initial runs were not so clean. The noise shown in Figure 16 appears in runs where
the sample band is not entirely flat and smooth and when the movement of fluid through
the separation chamber is too fast. It is of utmost importance to be careful when layering
the gradients and samples and collecting the fractions that the flow rate is slow and even.
Undesired movements within the separation column can cause waves that distort the
localization of the organelles and proteins.
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Figure 16. HRP, P-Hex, and BCA Assays from 5/8/05 DGE Run.
This is one of the few graphs available that demonstrate such an abundance of noise
caused by disturbances in the gradient. Future runs with sample bands that were
mushroom or donut hole shaped were often scrapped and repeated because it was known
that the separation would not be clean although some noise can also be seen in the graphs
in Figure 17 below.
Another contribution to abnormal peaks is bubbles in the assays. There is a sharp one
point peak in the beta-hexosaminidase assay to the left of the real lysosomal peak. This
was initially believed to be the lysosomal peak, but later re-analysis revealed that it was
most likely an error in the spectrophotometer reading due to bubbles. This is true
because the raw value of that particular was inconsistently higher than the range of values
in other beta-hexosaminidase assays.
The practice of popping all bubbles prior to reading the plates was added to the protocol
due to avoid anomalies like this graph. This is the only available graph that
demonstrates this peak, since all subsequent anomalies in enzymatic activity that were
caused by bubbles were detected during the spectrophotometer readings and addressed on
the spot.
Please note that out of the 84 fractions collected, every other fraction was used for
analysis via HRP, beta-hexosaminidase, and BCA assays. Thus, Figure 16 show results
for only 42 fractions, but should represent the 84 fractions. Therefore a peak at fraction
number 3 would correspond to a peak at fractions 5 and 6. Furthermore, note that,
despite the noise and abnormal additional beta-hexosaminidase peak, the segregation was
still relatively consistent with previous runs and Figure 15. The lysosomal peak was
localized to fractions 36 to 46 (18 to 23 on the graph), the late endosomes to fractions 41
to 50 (21 to 25 on the graph), and the early endosomes to fractions 67 to 76 (34 to 38 on
the graph).
4.4. Larger Fractions
Due to a need for more material for Western Blotting and Real-time PCR, fractions were
changed to be collected in 1.2 ml deep well dishes. This change applies to Figures 17
and onwards. Twenty four fractions instead of 80-90 fractions were collected, although
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Figure 17. 6/11/05 and 6/29/05 DGE Runs. Final version of protocols lead to
differences in assay profile: higher early peak, middle BCA coincides with late peak.
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Figure 17b does show 30 fractions. Thirty fractions were collected for that particular run
to ensure that 24 fractions were enough to cover the two endosomal peaks. Figure 17B
also demonstrates that the rising BCA activity in 17B does not rise indefinitely but peaks
a few fractions later. This large level of proteins accumulating at the higher Ficoll
concentrations is a concern when performing multiple DGE runs in series. It is very
important to make sure that for each run, the separation column is filled with fresh 10%
Ficoll and is not contaminated with proteins from the previous run.
With the new twenty four fraction cell collection, late endosomes consistently localize to
fractions 11-14 and early endosomes to fractions 18 to 21.
4.5. Increased Early Endosomal Peak
The heightened relative activity of early endosomes observed in 16 coincided with a few
sample preparation modifications made to the protocol since the DGE run shown in
Figure 15. This dramatic increase in the early endosomal peak is observed in all
subsequent runs as shown by the examples in Figure 17 and could be attributed to a
combination of factors.
4.5.4. Elimination of Whole Cell Spin - It is believed that the elimination of this first
centrifugation step allowed the retention of more material. It is suspected that the
early endosomal HRP signal increased significantly more than that of the late
endosomes because the early endosomes contain more HRP than the late
endosomes, so any increase in early endosomes results in a compounded increase
in HRP.
4.5.5. Change in Cell Culture - Another possibility is that the adjusted amount of HRP
delivered did not correlate the change from culturing 4 million cells in 10 cm
dishes to 2.25 million cells in 60 mm dishes. Thus the cells received a greater
concentration of HRP. Whereas the early endosomes reflected the greater amount
of HRP, the late endosomes sorted the extra HRP to other vesicles and thus the
collective amount of HRP in the late endosomal population remained relatively
unchanged.
4.5.6. Larger Fractions
The change from more and smaller fractions to less and greater volumed fractions
could have intensified differences in signal between the two peaks. This change
in protocol is basically acting like a multiplication factor in the y-axis direction,
so lower values increase at a rate less than the higher values. Thus, the
differences in the two peaks appear even more dramatic with the larger fractions.
4.6. Total Protein Peak
Another pattern observed in DGE Runs post-final modifications of the protocols was that
the majority of the proteins, which are visible as a faint white band due to optical
distortion by the proteins, moved with the late endosomes. The total protein assay
usually reveals three peaks, one near the top at the low Ficoll concentrations, one in the
center which coincided with the late endosomes and one at the high fractions, at the high
Ficoll concentrations. Sometimes the outside peaks are not observed because those
proteins have migrated past the region of sample collected. The middle peak however
consistently coincides with the late endosomal peak and is a good indicator of the
location of the late endosomes. This is observable in the graphs in Figures 16 and 17.
This characteristic is different than the migration patterns of the Mel Juso cells, which
showed that the middle protein band stayed with the early endosomes.
4.7. Maximum Protein Load
Maximum protein load was never directly tested during protocol development because it
was not considered a limiting factor. The old DGE device developed by Tulp allowed up
to 3.9 mg of protein, whereas each 60 mm dish of 2.5 million primary hepatocytes
usually yielded approximately 1 mg of protein. However, this issue arose when running
tests on six well tissue culture plates or running the density gradient electrophoresis on
two plates or more 60 mm plates.
For the DGE runs depicted in Figure 18, four 60 mm plates were pulse-chase-pulse
labeled with HRP and scraped and lysed. Duplicates of 4.65 ml (the equivalent of 1.7298
mg of protein) of the PNS was processed with trypsin and protease inhibitors and spun in
the ultracentrifuge to yield two organelle pellets. Each of the two organelle pellets was
subjected to density gradient electrophoresis, one run after the other. What is
demonstrated in the figure is the quantitative representation of the smear observed in the
column. Normally the white band expands a little during the electrophoresis but still
moves together. When too much protein is loaded, a smearing of the protein band is
observed.
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Figure 18. HRP assay for two DGE Runs on 7/13/06.
When too much protein is loaded into the DGE device, the organelles shield charges and
block one another's migration patterns and the organelles do not separate well. What is
seen is three endosomal humps. The middle endosomal hump is presumed to be a late
migration of more late endosomes. Thus, it is observed that the maximum protein load
for the DGE device varies from cell type to cell type, as the protein and organelle content
is different in different cell types. Perhaps the primary hepatocyte proteins and
organelles are bulkier or greater in charge. Furthermore, it recommended to not load
much more than 1.2 mg of protein for primary hepatocyte samples.
4.8. Repeatability
It is important to recognize that over a period of at least one year of experiments since the
protocol was mostly stabilized, the separation of the organelles have remained relatively
consistent with the organelles localizing to the same range of fractions run after run. The
repeatability of the density gradient electrophoresis device is a very important factor in
these quantitative experiments.
Not only is DGE device repeatable for good separations, it also repeatable in the bad
separations as shown in Figure 18. The DGE device is so faithful to its runs that even the
bad separations caused by too much protein are consistent with one another.
4.9. Conclusions
The simple assays confirmed that the separation of primary hepatocyte and HepG2
lysates into early endosomal and late endosomal fractions was possible and more
importantly, repeatable. The peaks were also sharper than those shown in the Tulp
experiments, demonstrating greater precision in the localization of the organelle
populations.
The next step was to prove that these peaks were indeed the late endosomal and early
endosomal fractions by performing western blotting on these fractions. The experiments
involved in this step are described in Chapter 5.
Please note however, the sensitivity of the process to disturbances and noise. It is why
chapter 2 and 3 go into so much detail about each step and emphasize the importance in
maintaining the integrity of the sample and later, the contents of the separation chamber.
5.0 Analysis of Fractions via SDS-PAGE and Western Blotting
To verify the horseradish peroxidase and beta-hexosaminidase assays, western blotting was
performed on the fractions. The following section details various aspects of the SDS-PAGE and
western blotting that were tested or customized. Initially, tests with just positive controls (just
pure cell lysate) in all the lanes plus the ladder yielded no signal. Every step along the western
blotting protocol was changed and tested many times as it was thought that the problem was with
human error perhaps in making the gels or the buffers or problems with the transfer. The first set
of problems discovered were with the buffers. Finally, testing with another person's lysates and
associate antibodies demonstrated that the problem did not lie in the protocol or the gels.
Another test with a new set of antibodies revealed that the problems were with the antibodies.
5.1. Controls
A number of different positive controls were used depending on the samples being tested.
Originally, the positive controls were whole cell lysates prepared as according to
Alexandria Sam's protocol as described below. Other positive controls have included
whole cell lysates from mechanical lysis via syringe in DGE buffer, the PNS from the
sample preparation as well as the leftover organelle pellet suspended in the 6% Ficoll-70.
Negative controls were typically lysis buffer without cells or the PES from the sample
preparation or different concentrations of Ficoll.
5.1.1. Lysis Buffer Method
1 million primary liver hepatocytes fresh from a two step collagenase perfusion
with greater than 90% viability were suspended in 1 ml of HGM in a 1.5 ml
eppendorf tube, spun down at 50g for 3 minutes (Brinkman Centrifuge 5804R) at
41C, and the supernatant was aspirated off. The pellet was frozen at -800C until
needed. The frozen cell pellet was defrosted on ice and lysed by addition of 100
tl lysis buffer consisting of 1% PMSF and 10% Protease inhibitor Cocktail
(AEBSF, Aprotinin, Leupeptin, Bestatin, Pepstatin A, E-64 from Sigma) in the
NP40 lysis solution (10 mM Hepes, 150 mM NaCl, 1% NP40). The cell pellet
and lysis buffer were incubated on ice for 10 minutes and then spun down at
10,000 rpm for 5 minutes at 40C. One experiment did involve comparing the
lysis buffer made according to the downstairs DAL lab protocol with the one
described above. It was decided that the above lysis method was simpler and
worked just as well.
5.1.2. Syringe Method
2.25 million primary liver hepatocytes fresh from a two step collagenase
perfusion with greater than 90% viability are seeded on a plate in 3 ml of HGM
overnight. Then the cell culture is washed twice with 3 ml of ice cold PBS and
once with 3 ml of ice cold DGE before being scraped in another 3 ml of ice cold
DGE buffer. Then the cells were collected and the suspension is incubated on ice
for twenty minute before lysis with syringe just like the DGE sample preparation
protocol described in Chapter 2. This method was used for making the positive
controls for SDS-PAGE runs that involved testing the DGE samples.
5.2. Running Buffer and Transfer Buffer Issues
Initially running buffer was used by diluting the 10x TGS into 1x TGS. However, the
gels were running weirdly (very slow or unevenly) so eventually running buffer was
made according to Appendix 13. Problems with the running and transfer buffer was
detected by a series of coomassie stains on the runs.
It was suggested by other lab members that 10x was too high a concentration and some of
the solutes might have precipitated and thus affected the actual concentrations of Tris,
Glycine and SDS used. Earlier runs could have had less solutes than required whereas
later runs that involved remixing the same bottle of 10x TGS may have had
concentrations of solutes that were too high, which would explain why the transfer step
caused the ladder to transfer through multiple layers of the Whatman papers beyond the
PVDF membrane.
Similarly to the running buffer, 2x transfer buffer is now made from dissolving Glycine
and Tris and adding SDS rather than diluting the 10x TGS. The methanol is added right
before use. After these changes were made, both the transfer and the SDS-PAGE
improved. The proteins stopped going past the PVDF membrane.
5.2.1. The Coomassie Stain
The coomassie dye stains proteins of different sizes and is used to determine the
success of the SDS-PAGE. As shown in Figure 19. The proteins of the positive
controls (eight lanes bluish lanes) and the ladders (lane 5 and lane 10) stop
running part of the way down the gel. Because the power source is constant and
the gels were ready made, the problem had to be with the running buffer.
Figure 19. Coommassie Stain. Proteins are not running down the gel as they
should.
The coomassie stain is also used to confirm full transfer of proteins of interest.
Usually the gels post-transfer only stained at the very top, where the highest
molecular weight proteins localized, indicating that all lower molecular weight
proteins had left the gel. Often the samples will be duplicated on another gel and
this second gel is stained with coomassie while the first gel is blotted via Western
Blotting. Other times, when very few well lanes are needed, the samples are
duplicated on the same SDS-PAGE gel and the gel is cut prior to transfer. One
part of the gel is stained, while the second part is transferred, then stained.
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5.3. Gels
Initially, gels were made according to the protocol described in Appendix 13. Variations
upon the protocol were tested, such as using ethanol instead of butanol, and then later
using a butanol-water combination. It was thought that the gels were poorly made but
comparisons between the self-made versus pre-made gels using Kevin Jane's positive
control proved that this was not the problem. The left gel was a Western Blot on a ready
made gel while the right gel was on a self-made gel.
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Figure 20. Comparison of Ready versus Self Made Gels. BioRad ready made gels
(left) were cleaner than the self-made gels (right). But the signal is approximately the
same, proving that the difference in gels was not the cause of problems as to why no
bands were being seen on the positive controls normally.
However, in the end, it was decided to just use Bio-Rad ready made gels to save time and
ensure the cleanest looking bands. The size of the proteins of interest required 7.5% and
10% gels. In order for loading the maximal amount of sample from the DGE runs, the
gel wells needed to fit 50 gl. The ordering information is available in Appendix 9. The
run proved
5.4. Transfer Step: Running Time and Voltage
Alexandria's protocol called for transferring overnight at 20 volts at 40C or 2 hours at 40
volts at 40 C. Previous experience in another lab used 100 V for 1 hour also at 40 C. All
three transfer conditions were tested and determined to yield indistinguishable results.
To save time, the transfers from then on were done at 100 volts for one hour at 40C.
5.5. Antibodies
Late endosomal fractions were identified with anti-Rab 9A (Santa Cruz sc-6562, Goat
IgG, 22.8 kDa) whereas anti-Rab5C (Santa Cruz sc-26571, Goat IgG, 24 kDa) was used
to identify the early endosomal fractions. A preadsorbed, HRP conjugated rabbit anti-
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goat secondary antibody (Santa Cruz sc-2922) was used for both. However, tests on
positive controls kept revealing unclear blots or multiple bands. Even after the buffers
were changed and the protocol was affirmed using Kevin's positive controls and
antibodies. So the next step was to test the antibodies themselves. It appears that
secondary antibodies are more prone to losing their integrity and ability to work properly.
Luckily a neighboring lab had a biotinylated form of anti-goat secondary antibody. This
required an additional incubation with HRP-conjugated streptavadin before detecting
with ECL reagent.
Testing revealed that the high background and lack of bands at the appropriate spot was
indeed a problem caused by the secondary antibody, as the biotinylated form showed nice
clear bands.
250
150
100
75
50
37
25
20
Figure 21. Using a Biotinylated Anti-Goat Secondary Antibody. Left: Goat anti-
Rab9A used on four lanes of whole cell lysate. Right: Goat anti-Rab5C used on four
lanes of whole cell lysate.
The left blot in Figure 21 incubated with anti-rab9 showed three sets of bands, the lowest
being at the correct 22.8 kDa. The right blot however showed only two set of bands,
none of which were at the correct molecular weight. It is believed that the two sets of
higher bands was an artifact of the biotinylated anti-goat antibody. This set of blots was
the first of many that suggested that Rab 5 should not be used to detect early endosomes.
A new, non-preadsorbed version of the HRP-conjugated rabbit anti-goat secondary
antibody (Santa Cruz sc-2768) was purchased and new western blotting was performed.
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Figure 22. Using the new HRP -conjugated anti-Goat Secondary Antibody. Left:
Goat anti-Rab9A used on four lanes of whole cell lysate. Right: Goat anti-Rab5C used
on four lanes of whole cell lysate.
The Rab9 antibody worked even better with this new secondary antibody, showing the
strongest bands at the correct molecular weight. However, the new antibodies proved
that the anti-Rab5 was a dud. Even with the new secondary antibody, the results were not
good. The band should be at the 26 kDa location, but as seen in Figure 22, right blot, the
26 kDa location only shows a faint band at 26 kDa with multiple darker bands right
above.
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Thus, the primary antibody for early endosomal fractions had to be switched to anti-
EEA1 (BD Biosciences, Mouse IgG1, 180 kDa). This larger protein requires 7.5% gels
and another secondary antibody (Amersham Biosciences, HRP conjugated sheep anti-
mouse). This antibody worked much better as shown in Figure 23 below.
Figure 23. Anti-EEA-1. ant-EEA1 is better primary antibody for early endosomes. The
bands are clear and at the correct molecular weight of 180 kDa.
5.6. Blocking.
Initially blocking was done with 1-3% BSA, however, the blots exhibited high
background. So the blocking solution composition was switched to 5% milk in TBS-T.
The milk is made fresh from dry milk powder. Enough milk is made for blocking (-30
ml per blot) and for secondary antibody incubation (30 ml per blot). With the above
changes, the positive controls were finally visible and clear.
5.7. Sample Buffer
Reducing and non-reducing buffer was made according to the formulations in Appendix
10 and compared. 2x Sample buffer from National Diagnostics was also tested to see if
the different buffers affected the way the samples ran down the gel.
Reducing sample buffer seemed to be slightly better for the Rab9 blots and significantly
better for the EEA1 blots. The first two lanes were PNS + 10% Ficoll Precipitated, the
second two lanes were PNS + 5% Precipitated, and the third two lanes were PNS + DGE
Precipitated. The seventh lane was just regular PNS and the eight and ninth were whole
lysates and the tenth lane was the ladder. The reducing sample buffer seemed to
eliminate the differences in the presence of Ficoll in the Anti-Rab9 blot. For the EEA1
blots, the reducing sample buffer seemed to help the migration of the sample. The non-
reducing blot's sample did not separate well whereas the reducing blot had the EEA-1
proteins migrate much more. It is believed that the migration was slowed by the Ficoll as
demonstrated by angle in the reducing Anti-EEAl blot. There was more migration as the
amount of Ficoll decreased. Furthermore, it seemed as if the reducing sample buffer was
counteracting the Ficoll effects. Thus the SDS-PAGE experiments afterwards all used
reducing sample buffer.
Figure 24. Reducing vs. Non Reducing. Experiment performed Aug 18, 2005
comparing the effects of reducing and non-reducing sample buffer on Rab9 and EEA 1
blots.
5.8. Changes in Transfer Materials
Additional minor changes were made to some of the transfer materials but these changes
did not affect the outcome. Initially the membrane and gel were sandwiched by 6 and 9
thin "Whatman" papers cut from 20 x 20 Chromatography paper pre-wetted in the
Reducing Sample BufferNon- Reducing Sample Buffer
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transfer buffer. Later, thick "Whatmans" were purchased from BioRad and used instead.
The thick Whatmans were more convenient, but sometimes the gel sticks to the Whatman
during the transfer process and is thus in no condition to be stained by coomassie. Refer
to Appendix 9 for ordering information. Secondly, another change made in transfer
materials was switching from pre-cut PVDF membranes to the cheaper, roll of PVDF.
Pieces of the PVDF membrane were cut using the short plate as a template for the size.
5.9. Results
After the various problems with the entire Western Blotting process were resolved;
testing on the DGE fractions began. First, western blotting was done only on the fraction
with the highest activity. However, there was no signal from the tested fractions.
5.9.1. Antibody Concentration
Initially, the primary antibody concentration was 1:1000 and the secondary
antibody concentration at 1:10,000. It was upped to 1:250 and 1:2500 for the
primary and secondary respectively and the time on the developer decreased
dramatically from thirty minutes to five minutes and later on three minutes.
5.9.2. Developing Reagent
The membranes were washed three times and incubated with the luminescence
reagent (Western Lightening) for 1 minute before image via a Kodak Developer.
Later, the developing reagent was switched to a special ECL solution made by
Amersham Biosciences for protein blots that were especially hard to detect.
Despite these changes, the DGE fractions could not be visualized even though the gels
were running correctly according to Coommassie Stains and the positive controls were
visualized on the blots.
5.10. Protein Load Calculations
Finally it was determined that the amount of total protein sample being loaded into each
50 [l well was too insignificant to be detected using some back of the envelope
approximations and calculations.
Using a series of lysis experiments and BCA tests it was determined that the lysate of
100,000 seeded cells is approximately 24 jpg of total protein. This was determined by
lysing many 4 million cells in 2 ml of DGE buffer and determining that the amount of
protein in 50 gl is 24 jig. Currently, the experiments involve lysing 2 million cells in 400
[l of lysis buffer per million cells since the amount of lysis buffer is doubled to ensure
full lysis. For SDS-PAGE an equal volume of 2x sample buffer is added. Thus 2 million
cells are now suspended in a total of 800 [l solution. Only 50 gl maximum is loaded into
each well of the polyacrylamide gel, so that would be the equivalent of 125,000 cells per
well. Thus using the above calculations, it would mean that approximately 30 jLg of total
protein is loaded into each well for the positive controls.
For the DGE samples. 4 million cells were lysed and processed and then electrophoresed
over a separation column with a volume of a approximately 25.5 ml. (Later this is
changed to 2.25 million cells in 30 ml, but the order of magnitude is similar). Now only
25 jll of sample maximum can be loaded because the largest well size is 50 [l and the
other 25 jil has to be the 2x sample buffer. 25 jl is approximately 1/1000 of 25.5 ml.
Thus, the equivalent of 4,000 cells is being loaded into a well, which translates to
approximately 1 jlg of protein. This is also assuming that the protein and organelle
distribution is equal across all 25.5 ml which it isn't.
Furthermore, the sample preparation process was later changed to 2.25 million cells, and
it was calculated that approximately 1 mg of protein was being loaded into the DGE
device. Twenty fractions are collected at 1.2 ml each, which is the equivalent of 28.8 ml
total for that 1 mg of fraction. Thus 25 jl of would be approximately 0.86 jig of protein.
The maximum load for SDS-PAGE and western blotting is 50 jig. The DGE fractions are
less than 1/50 of that load. It was necessary to determine a way to load more protein into
each well, which is what is discussed in chapter 6.
6.0 Concentrating the Endosomal Fractions
As described in chapter 5, neither EEA1 or Rab9 protein was being detected via Western
Blotting in the DGE fractions that had huge HRP signaling despite testing all aspects of SDS-
PAGE Western Blotting. It was finally determined that the sample size was too little. The
fraction size collected from the DGE runs were switched from 300 gl to 1.2 ml so that 500 gl
could be used for this purpose. This would be approximately 17 gg of protein which should be
on the order of detectable protein. The first method used for concentrating this 500 pl into 50 [l
was precipitation.
6.1. Precipitations
Many different precipitation protocols including acetone, Trichloroacetic Acid (TCA),
TCA plus acetone, ethanol, and TCA-DOC were tested.
6.1.1. TCA Precipitation on Controls
The appendix lists variations on the protocols, but the general protocol consisted
of adding cold trichloroacetic acid to a final concentration of 10% volume to
volume to each fraction (500 gl) and incubated on ice for thirty minutes. The
precipitated proteins were centrifuged for 15 minutes at 10,000 rpm 40 C
following an adjusted protocol developed by collaborators at the Netherlands
Cancer Institute. The supernatant was decanted and the pellet resuspended in 50
pl of sample buffer (a 1:10 concentration).
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Figure 25. TCA Rescues Dilutions.
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Figure 25 demonstrates that the TCA precipitation successfully concentrates
protein solutions. The first lane is a 1/90 dilution of the cell standard compared to
the next two lanes which are 1:10 precipitations on the 1:90 dilution. The
precipitation would thus be equivalent to a 1:9 dilution of the cell standard.
Next, the fourth lane is a 1:30 dilution compared to two lanes of 1:10
precipitations of the 1:30 dilution. The precipitated 1:30 should thus be
equivalent to a 1:3 dilution. The signal of that lane does appear to be about one
third the signal of the positive control. Overall, these results show that the
precipitation can rescue even a 1:90 dilution from being invisible to making it
become apparent, even though the signal is weak. Remember, the originally DGE
samples were approximately 1:50 of the load maximum, so the 1:10 precipitation
should produce detectable bands.
6.1.2. TCA on DGE Fractions
However, problems occurred with TCA precipitations of the DGE fractions. As
shown in Figure 26, the precipitated samples created dark clouds in the gel -
perhaps something reacted with the polyacrylamide gel. The other notable
characteristic is that the samples mostly remained at the top at the wells and did
not travel down with the exception of the positive controls which were the same
un-precipitated lysates. They still had the same three bands characteristic of the
anti-Rab9 antibody.
Originally, it was believed that the samples were stuck at the top of the wells
because they were not fully re-suspended and dissolved in the sample buffer prior
to loading. Furthermore, the acid from the TCA was thought to react with the gel.
The Tulp lab suggested adding small volumes of 2M Tris if the solution remained
too acidic - indicated by yellow color - until the sample buffer's deep purple
color returned and sonicating after addition of Tris for at least half an hour until
the pellets were fully dissolved. Only after the pellets were dissolved should they
be frozen for later use.
Figure 26. Rab9 on TCA Precipitated Samples.
These two suggestions were implemented. However, it takes approximately 30
minutes to one hour to dissolve the pellets. Furthermore, sometimes the sample
turns purple after mixing with a little bit of Tris but sonication may cause the
sample to turn yellow again, indicating high acidity. If so, the pellet will not
dissolve even after sonicating for over two hours. Moreover, even after these
changes, the samples were still remaining stuck at the top as shown in Figure 26.
6.1.3. Multiple Precipitation Methods Tested
Ethanol only, acetone only, TCA only and TCA plus acetone were all tested to
see if the precipitations would be different. However, the same problems were
still resulted. The pellet remained gummy after the centrifugation and was
difficult to resuspend. Furthermore, even after re-suspension with the help of Tris
and sonication, the signal continued to stay at the top of the wells despite
coomassie stains that showed that proteins were running down the gel as shown in
Figure 27.
Figure 27. Comparing Acetone only to TCA-Acetone Precipitation. Top:
Coommassie gel stain. Bottom: Rab 9 Western Blot of the same SDS-PAGE. NP
= not precipitated, A = Acetone only, TA = TCA-Acetone. 500 = 500,000 cells,
100 = 100,000 cells, 50 = 50,000 cells.
The acetone precipitation of the 100K cells seemed to develop the clearest bands
and looks most similar to the 500K unprecipitated control. However, in the
western blot, the TCA had greater signal.
6.1.4. Large Fraction Precipitation
Next, fractions were pooled so that 1 ml samples could be precipitated into 100 [tl
samples. The Large Fraction TCA Precipitation was done as according to
Appendix 14. However, the results were similar.
6.1.5. Ficoll Tests
It was then suspected that Ficoll was precipitating along with the proteins and
then it was interacting with the proteins of interest, preventing their
electrophoresis during the SDS-PAGE. The pellets seemed to increase with the
fraction number being precipitated such that the fractions that were suspended in
higher Ficoll densities had bigger pellets during precipitation. So Ficoll tests
were performed multiple times. One result is shown below.
Figure 28 demonstrates the effect of Ficoll. As more Ficoll is added, the
cloudiness at the top of the gel increased and the signal decreased. Precipitations
that included Ficoll had an insoluble pellet that was difficult to suspend and load
with a thin tip. Thus samples were only loaded from the top. The greater the
amount of Ficoll in sample, the less proteins were left in the supernatant to be
loaded and also the greater amount of Ficoll also loaded into the gel. Thus, more
fuzziness and yet less protein signal.
Lanes 2 through 4 were controls. Lane 3 showing that adding 10% Ficoll
normally does not have an effect but after for lanes 5 through 7, the Ficoll is
concentrated along with the proteins and now the effect of the Ficoll is much
greater.
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Figure 28. Ficoll Test. For lanes 3 and 5 through 7, 0 to 10% Ficoll in DGE
buffer was added. WC= whole cell. PNS = post nuclear supernatant. Only lanes
5-7 were precipitated. Lanes 8 through 10 (not shown) were duplicates of 5-7.
6.1.6. TCA-DOC Precipitation
Trichloroacetic acid precipitation in conjunction with deoxycholate (DOC) was
also tested. This variation was suggested for precipitating small quantities of
protein as the DOC would associate with the proteins to help increase the
precipitations of the protein with respect to the Ficoll. A special ProteoPrep kit
was also ordered for this purpose. However, this variation did not improve the
results.
6.2. Dialysis
Because the Ficoll was interfering with the precipitations, it was decided that the Ficoll
needed to be dialyzed out of the samples prior to running on Western Blots.
Furthermore, the dialyzed samples could be concentrated by an acrylamide powder.
Thus, the dialysis method was first tested on the lysate of cells that were pulsed labeled
with HRP. The cells were dialyzed for three times in cold lx PBS in the cold room at
40C with a spinner keeping the PBS circulating. The PBS is to keep the solution isotonic
with organelles so they do not lyse and leak HRP. The first two dialyses are incubated
between one to three hours and the last one is done overnight. The first two have shorter
periods because the majority of the materials being dialyzed out would move during the
first two incubations. It is important to do these two PBS changes to maximize the
dialysis and the diffusion of the Ficoll and other materials so that the organelles could be
isolated. After dialysis the sample was condensed for 1.5 hours with 10 grams of the
acrylamide condenser until about 2 ml of solution was left. Then the samples were tested
for HRP signal before and after dialysis. The HRP signal was still present. Then, the
experiment was repeated, this time the dialyzed sample is the organelle pellet re-
suspended in 5% Ficoll and then dialyzed.
Table 1. Dialysis Comparison in Presence of Ficoll
Before Dialysis After Dialysis
0.744 0.688 0.659 1.144 1.063
HRP
AVG = 0.697 AVG =1.104
0.121 0.147 0.129 0.266 0.241
Beta Hex
AVG = 0.132 AVG = 0.254
As shown in Table 1, the dialysis was able to increase protein concentration almost two
fold. If the dialysis tubes were concentrated to well below 1 ml, perhaps the
concentration could be increased four to eight fold.
Thus, a DGE run was performed and fractions were assayed for HRP activity. The late
endosomal peak fractions were pooled and the early endosomal fractions were pooled.
Each dialysis tube could contain up to 5 ml of sample so four to five fractions were taken
for the late endosomal pool and four to five for the early endosomal pool. As shown in
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Figure 29. Western Blot on Dialysis. Fractions pooled from the early and late endosomal peaks
of the HRP assay (A) underwent dialysis and were examined via Western Blotting (B and C).
The left picture (B) was blotted with anti-rab9 and the right picture (C) was blotted with anti-
EEA-1.
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Figure 29, fractions 9 through 13 and fractions 17 through 21 were pooled for the late and
early endosomes respectively.
They were dialyzed overnight with the two changes of PBS buffer. Then the dialyzed
samples were run on western blotting. Ten lanes were run but four lanes were cut off
prior to the transfer step to be tested via coomassie.
As shown in Figure 29, the dialysis did not work well for the DGE fractions. There were
still no results. One possible reason could be that the endosomes lysed during the
overnight dialysis causing the endosomes to leak out into the buffers. Because the
volumes of the PBS buffers were so large to increase dialysis, the material would be too
dilute to be detected.
6.3. Ultracentrifugation
Finally, we decided to pool the late and early endosomal fractions respectively and do
another ultracentrifugation. Since the endosomes spun down in the first ultracentrifuge,
the fractionated organelles should also be able to spin down. This method was actually
successful for the late endosomes. Unfortunately for the early endosomes, the pellet if
existent was too small to be seen and re-suspended in sample buffer.
6.3.1. Late Endosomal Fraction
For the late endosomes, the freshly collected fractions from a normal DGE run of
HRP-labeled cells were tested via the HRP assay. The fractions in the first HRP
peak were pooled into a centrifuge tube and the fractions of the second HRP peak
into another centrifuge tube. The late endosomes spun down into a small pellet.
Western blot testing revealed that the late endosomal fraction contained a pure
late endosomal population, as Rab 9 signaling from the pellet was significantly
higher than signaling from the positive control, a hepatocyte lysate. EEA1
signaling was significantly lower than the signaling from the positive control.
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Figure 30. The Late Endosomes Population. Fractions 9 through 13 were pooled,
ultracentrifuged, and its pellet re-suspended and loaded in an SDS-PAGE gel. It was blotted
against aAnti-Rab9 and anti-EEA-1 antibodies to prove that these fractions did contain late
endosomes and the late endosome protein marker Rab9.
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This ultracentrifugation method was able to prove that the HRP assay at least for
the first hump was correct. The first hump indeed contained Rab9 and did not
contain EEA 1 so the first HRP peak was indeed representative of the late
endosomal population.
6.3.2. Early Endosomal Fraction
Because the pooled fractions of the early endosomal peak did not provide enough
material to have a re-suspendable pellet, two density gradient electrophoreses
were run consecutively, each on the lysates of two 60 mm dishes with 2.5 million
cell s seeded each. The protein loaded into each DGE run was approximately
1.7298 mg compared to the usual 1 mg. This high protein proved to hinder the
separation of the organelles as described in Chapter 4, Section 7. However, the
early endosomal peak was still quite distinct and the fractions that had the highest
signal were pooled. However, even with all this material, the ultracentrifugation
spin of one hour yielded a miniscule pellet.
Nevertheless the supernatant from the spin was discarded and the "pellet" was re-
suspended in sample buffer and frozen. The sample was loaded the next day for
SDS-PAGE and Western Blotting, and as expected, no signal for either.
6.3.3. Conclusion
Despite being unable to directly prove that the second peak is early endosomes,
what can be proven is that the PNS contains both early and late endosomes as
shown by the signals in blots labeled with both anti-EEAl and anti-Rab9.
Furthermore, the first peak contains Rab9 but not EEA1. Thus, it indirectly
proves that the second endosomal peak should be the early endosomes which
would contain EEAl but not Rab9. Additionally, experiments have been
performed where only a three minute HRP pulse is given to the cells followed by
immediate lysis. This should only label early endosomes, and indeed, only a
single peak in the expected fractions is detected, thus substantiating these results.
7.0 Effects of Gene Vectors
The DGE device has also been tested on cells that have been transfected with non-viral gene
vectors. Originally PEI vectors were tested to ensure that the protocol would not have to be re-
optimized. This past year, most testing has occurred on the new generation vectors, testing their
localization over different points.
This thesis will not cover the actual results of the gene deliveries but rather stick to the main
point of this thesis, which is proving that this DGE device works well in separating the
organelles of interest and is able to do so in the absence and in the presence of these various gene
vectors, viral or non-viral. The conclusion from these preliminary results is that the gene vectors
have had little effect on the separation integrity of the organelles via the density gradient
electrophoresis.
7.1. Polyethylenimine (PEI) Vectors
The cationic polyethylenimine (PEI) vectors are good candidates for the DGE tests
because they have had preliminary success [61] and are very common and popular in the
non-viral gene delivery research field. Their success is attributed to the protonatable
nitrogen atoms which acts as a proton sponge in acidic late endosomes and lysosomes
[62] preventing the increasing acidity of endosomal maturation. This results in osmotic
swelling followed by lysis of the endosomal and lysosomal membranes [29, 62] resulting
in enhanced endosomal escape. More information and characterization of PEI vectors are
available in many papers [12, 25, 63, 64, 65].
Upon addition of the PEI vectors, the fractions were expected to shift due to the presence
of these cationic polymers, but results have shown that the organelle membranes act as a
capacitor and block the charge effects of these gene vectors. If true, then separation
patterns will only shift downward in the column as a function of increased vesicle
density.
What is observed in Figure 30 is precisely this shift. This round of DGE runs also
included testing cells that were incubated with the PEI25 vector to see if the vectors
inside the organelles would affect the migration of these organelles in the DGE run. The
late endosomes are now localized to fractions 12 through 15, rather than 9 through 13 as
indicated by both the HRP and BCA humps. The beta-hexosaminidase activity still peaks
at fraction 11 or 12 and the second HRP activity peak is at fractions 19 through 21 with a
small shoulder at 17 and 18.
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Figure 31. 6/18/05 DGE Run. 2 hour PEI gene delivery. N/P = 20.
Table 2. Mean Effective Diameter
PEI25 Trial 1 Trial 2
NP 10 636.0 nm 459.4 nm
NP 20 261.6 nm 172.6 nm
NP 30 201.2 nm 154.0 nm
The number in PEI25 refers to the N/P ratio, which compares the amount of nitrogens (on
the vector) to the amount of phosphates (on the DNA). This ratio is important because as
the N/P ratio increases, there is tighter binding and the size of the vector-DNA complex
decreases which affects its delivery [66].
7.2. Next Generation Vectors
The DGE will be used to test new vectors that demonstrate improvements in delivery
compared to the old PEI25. The first is not a PEI, but a poly-beta-amino ester, whereas
the second is a cross linked version of the PEI. It is hoped that insight can be elucidated
as to why these newer vectors are more effective.
7.2.1. C32 C32
The C32 vector is a poly-beta-amino ester that was
discovered to be highly effective in gene delivery in mass screenings [67]. It has
been used to successfully deliver DNA encoding toxins to cancer cells [68]. The
mass screenings involved combining amino and diacrylate monomers to make
polymer libraries [69, 70, 71] and testing these extensive libraries on biomaterial
microarrays [72, 73] developed in the Langer Lab. Poly-beta amino-esters are
good non-viral vectors because they are biodegradable and share similar proton
sponge properties while being less toxic than PEI. Furthermore, they make more
compact particles than PEI vectors which is better for trafficking [68, 74].
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Figure 32. Monomer Libraries. The number indicates the amino group and the
letters indicate the diacrylate. (from Anderson et al. 2004 [68, 71], extended
version in Anderson et al. 2003 [75])
Like the PEI vectors, the C32-7 only shift and broaden the peaks minimally so
their trafficking can still be studied. What is interesting though is that lysis is
difficult for gene deliveries beyond two hours. After the typical lysis procedure,
many whole cells still exist but are leaky and nuclei are also leaky. However, this
lysis problem is not so significant in the interests of measuring vector trafficking
kinetics because C32 is so efficient and thus, the 4 hour time points aren't
necessary and rather a 10 minute time point has been added to the general
protocol.
Another observation is that after the ultracentrifuge spin, the organelle pellet has a
white frill created by broken membranes that is not observed in PEI or X-linked
vectors. This could indicate enhanced vesicular escape that will be elucidated in
future analyses.
7.2.2. Small X-linked PEIs
The X-linked gene vectors are low MW branched and linear PEI polymers that
can be cross linked by DSS. The degradable linkages helped increase the
molecular weight of the vectors while still maintaining the proton sponge
character and compact particles provided by the standard high MW PEIs and
while affording the lower toxicity of low MW PEIs, which alone are typically
highly inefficient [76]..
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n = 11.6, Branched polyethylenimine, 2-kDa n = 4.9, Linear polyethylenimine, 423-Da
Figure 33. The small PEIs and the DSS used for cross-linking. (Figure from
Thomas et al. 2005 [76])
X-linked gene vectors were just beginning to be tested at the time of this thesis
writing - at least one set of the time points were completed, and the second set
was partially completed. X-linked vectors do not seem to affect the sample
preparation or DGE runs significantly, and will also be evaluated further in future
studies.
7.3. Conclusion
Preliminary data has shown that the distortions on the separation patterns of the late and
endosomal organelles caused by the gene vectors is minimal and insignificant.
Therefore, the sample preparation protocol and DGE protocol do not need to be changed
to accommodate the presence of the gene vectors. Furthermore, this confirms that the
DGE device can be used to study the trafficking of these novel vectors to see if they
differ in cell-vector interactions or why they are better than their predecessors.
8.0 Conclusions and Future Directions
The density gradient electrophoresis process was modified for the use of isolated perfused rat
liver cells. In order to prevent complications in the lysis of cells, minimal extracellular matrix
was used in the liver tissue culture. To ensure that the liver cells stayed differentiated and
remained an accurate representation of in vivo liver cells, only 24 hour cultures were used. It
was discovered that many of the hepatocytes were lysed during the scraping process, so the spin
step before lysis actually eliminated a large population of the sample. Thus, the spin step before
the lysis was taken out of the protocol to preserve as much sample as possible. Lysis seemed
optimal with a long needle (2 inch) and a thin diameter (21 G). Lysis was also supplemented
with the addition of trypsin and other enzymes.
Subcellular fractionation processes used prior to the development of the density gradient
electrophoresis device were unable to separate early and late endosomes from one another, and
lysosomal fractions could only be separated from the two endosomal populations combined after
two extensive 24 hour long centrifugation processes. Exploiting the charge and density
differences of each of organelle species, the density gradient electrophoresis device now allows
for easy separation of early endosomes, late endosomes, and lysosomes from the nuclei and
cytoplasm of rat hepatocytes. The repeatability of the DGE process is demonstrated by the HRP
peaks: the late endosomes consistently localize to fractions 11-14 and early endosomes to
fractions 18 to 21. The beta-hexosaminidase assay also demonstrates that the segregation of
lysosomes coincides with the late endosomes at fractions 11 through 14.
This thesis work has demonstrated that DGE can be used to separate the early and late
endosomes of rat hepatocytes from one another by more than four milliliters and furthermore,
confirmed the presence of late endosomes and absence of early endosomes in the late endosomal
peak. The early endosomal peak can be indirectly proven by the existence of EEAl signaling in
the organelle pellet but lack of EEA1 signaling in the late endosomal peak. Furthermore, the
vectors tested have minimal impact on the segregation of the organelles. Thus, the same
protocols can be used for cells transfected with gene vectors.
With DGE, scientists can now study the endosomal system in greater detail, allowing for two
major benefits. First, scientist can see how the vectors are interacting with the endosomal
system and determine which steps along the pathway are stalling the vector. They quantitatively
assess delivery efficiency of the gene vector at each step within the endosomal system.
Previously, gene therapy research involved making small modifications in just one or a few
aspects and observing how they affect the overall performance of the vector. There was little
understanding of how the modifications affected specific aspects of the delivery because no tools
existed to allow for such detailed assessment. With advances in DGE, researchers can now see
how changes in the vector affect the rates at which the vectors are shuttled through different parts
of the endosomal system because the various organelles in the endosomal system can now be
isolated and analyzed.
Secondly, armed with an understanding of the endosomal system, researchers can determine
which steps along the endosomal pathway are most important in influencing gene delivery
efficiency and make specific modifications to their vectors that are targeted to those specific
steps. By separating the various endosomal pathway organelles, the amount of gene vectors in
each organelle population could be determined over various time points to determine the rate at
which the vectors travel through each step of the pathway. The effects of modifications of gene
vectors can now be observed and modeled as changes in the kinetics of each step and knowledge
of how the kinetics change can guide further modifications in the gene vectors.
Current non-viral gene therapy research is untargeted - the modifications are made without a true
understanding of which steps along the delivery pathway are most important and influential in
the delivery of the gene. With DGE and new computational biology techniques [8], it is now
possible to look at the effect of one characteristic change upon the different steps of the
subcellular trafficking process as well as look at how multiple modifications interact with one
another. Using a mathematical model for cellular uptake, trafficking, nuclear localization and
expression mathematical model of the endosomal pathway kinetics, the key steps of this complex
process can be identified. The entire subcellular trafficking process can be modeled as a series
of first order kinetic rate processes that result in transporting the studied gene vector or drug
through the endosomal pathway.
When the gene vector is modified, the changes in subcellular trafficking in response to that
modification can be examined and also modeled as changes in various rate constants. Thus,
multiple modifications can be compared and analyzed to reveal how to most favorably modify
each property to increase the efficacy of the gene vector. Further study will determine which
physical characteristics or properties are most critical or most significantly influence the
principle steps previously established. Thus, modeling the effects of various vector
modifications on its gene delivery efficacy and kinetics will enable us to make targeted
modifications to the current vectors. Moreover, the sum effects of various modifications could
be predicted.
Although not covered in the bulk of this thesis, work has already begun in developing time
courses of the trafficking kinetics of PEI and poly-beta-amino-ester vectors. The time course is
developed by running DGE on cells lysed at various time intervals post gene vector delivery.
Then the DNA is purified from the DGE fractions and analyzed via real-time PCR to detect the
location and levels of the gWiz 3-gal vector in each compartment. Originally, gene delivery
DGE runs were performed on cells dosed with PEI25 vectors but now the focus is on the new
generation vectors: the X-linked and C32-7. Right now, there is preliminary data on the time
courses of the new generation vectors, showing efficient delivery. Adenoviruses are also being
tested for comparisons between viral and non-viral delivery efficiencies. It is hoped that
determining the kinetics of viral delivery can help non-viral researchers mimic their movements
and achieve the same delivery efficiency.
Further improvement to the DGE separation process can be explored to allow for separation of
other endosomal organelles such as plasma membrane and golgi network organelles [58]. For
example, lectin [57] has been used to separate out the plasma membrane from the other
organelles in the DGE. Other physical characteristics of the organelles can be exploited such as
modifying the pH of specific endosomes [77], changing the temperature [38] and changing the
trypsinization of the cell lysate [58]. Other considerations include changing the conductivity of
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the buffer or using a salt based separation medium [78] such as potassium phosphate [79] and
Calcium ions [80] and to explore the permeability differences of the organelles. Techniques
used in other separation methods could also be applied to the DGE device. Lysosomes have
been purified with Percoll centrifugations, but in order to do so, either detergents [81] or iron-
complexes [82] were added to change the lysosomal densities. FFE [37] requires manipulating
the physical characteristics of the organelles such as increasing the acidity of the late endosomes
[83]. It would be interesting to try some of these techniques to enhance separation and create
sharper bands of organelles.
The greater resolution at which the endosomal pathway subdivided into organelles will lead to a
better mathematical model of the delivery kinetics and permit a better understanding of the
modifications of the vectors on various aspects of the pathway, and ultimately, aid in the design
of highly efficient and effective non-viral gene vectors.
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Appendix 1 - Hepatocyte Growth Medium (HGM) Formulation
HGM is made by adding the following to 500 ml of Dulbecco's Modified Eagle Medium
(GIBCO #11054-020, low glucose, pyridoxine HC1, sodium pyruvate, no glutamine, no phenol
red).
Amount Ingredient Final Conc. Storage Catalog #
0.15 g L-Proline 0.03 g/L RT Sigma P-4655
0.05 g L-Ornithine 0.1 g/L RT Sigma 0-6503
0.153 g Nicotinamide 0.305 g/L RT Sigma N-0636
0.5 g D-(+)-Glucose (media already has lg/L) 2.0 g/L RT Sigma G-7021
1.0 g D-(+)-Galactose 2.0 g/L RT Sigma G-5388
1.0 g Bovine Serum Albumin Fraction V 2.0 g/L 40C Sigma A-9647
5 il ZnCl2  0.0544 mg/L RT
5 il ZnSO 4 -7H20 0.075 mg/L RT
5 tl CuSO4 -5H20 0.02 mg/L RT
5 [l MnSO 4 0.025 mg/L RT
The solution is then filter sterilized before adding the
Amount Ingredient
5 ml Penicillin -
Streptomycin
2.5 ml L-Glutamine (100 ml)
400 •l Dexamethasone
500 p• Insulin-
Transferrin-
Sodium Selenite
following in
Final Conc.
10 unit/mL
10 tg/ mL
5.0 mM
0.1 tIM
5 mg/L
5 mg/L
5 Lg /L
the culture
Storage
- 20 0C
- 20 0C
- 20 0C
- 20 0C
room fume hood.
Catalog #
Sigma P-0781
Gibco 25030-081
Sigma D-8893
Roche 1074-547,
1213-849
The last component is added to medium immediately prior to first use.
Amount Ingredient Final Conc. Storage
200 pl Epidermal Growth Factor (EGF) 20 ng/ml - 200 C
Catalog #
Collaborative
40001
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Appendix 2- Materials Needed for Cell Culture and Density Gradient Electrophoresis
Description Amount Price
Beckman Instruments
Optiseal Polyallomer Centrifuge Tubes - Bell
361623 Top (5/8 x 2 3/8 in. capacity = 8.9 ml)
BD Biosciences
354236 Collagen Type 1 Rat Tail (3.1 mg/ ml)
Corning Incorporated
3008 Costar Cell Lifter (polyethylene, sterile)
Box of 50 tubes
and caps
100 mg
Dow Corning
508-008
Gibco
10010
Nuncbrand
442587
260252
Silastic Brand Laboratory Tubing
(ID=1.57mm, OD=3.16 mm)
PBS pH 7.4
V96 MicroWellTM Plates
U96 DeepWellTM Plates 1.0 ml
LabCor Products
730-001 Solution Basins 55 ml
Radioshack
3-12 Volt 800 mA AC adapter
Fluke 73VI multimeter
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Catalog #
lx 50ft
100 pieces
Horseradish Peroxidase Type VI-A
Leupeptin (Acetyl-Leu-Leu-Arg-al
Hydrochloride)
Sigma
P-6792
L-9783
VWR
305129
309602
309585
309653
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BD Precision Glide Needle 21G2
BD 1 ml Syringe Tuberculin Slip Top
BD 3 ml Syringe Luer Lok Tip
BD 60 ml Syringe Luer Lok Tip
100 mg $266.50
Box of 100
Appendix 3 - Buffers and Solutions for DGE
A. DGE Buffer
The DGE Buffer is used in both sample preparation and the actual density gradient
electrophoresis run itself. To make DGE buffer, combine the following ingredients.
for 500 mL for 1 liter for 2 liter
250 mM sucrose (g) 42.78 85.56 171.12
10 mM acetic acid (ml) 0.286 0.572 1.144
10 mM triethanolamin (ml) 0.6665 1.333 2.666
NaEDTA
1 mM (Titriplex) (g) 0.186 0.372 0.744
Then add MilliQ water until within 5% of the desire final volume.
pH to 7.4 with NaOH and then fill with MilliQ water to the final volume.
Typically, three to four 2-liter bottles of DGE buffer are made at a time (total of eight
liters). A 2-liter bottle of DGE buffer can typically last for about six to eight DGE runs if
you recycle the bottom chamber buffer.
B. 10% Ficoll-70-70
Typically, one or two liters of 10 % Ficoll-70-70 are made, using ten or twenty grams of
Ficoll-70-70 dissolved in one or two liters of DGE buffer respectively. The Ficoll-70-70
powder is very light and floats easily so be careful when measuring and use a cap when
putting the solution on the stirrer plate. The Ficoll-70-70 also takes a long time to
dissolve - around one hour. Usually the 10% Ficoll-70-70 is made in a bottle with a
screw cap so that it can be inverted and shaken to help the dissolving process. Once the
Ficoll-70-70 is dissolved, the entire solution should be clear. It may be a good idea to de-
gas the solution if using immediately.
C. 5%, 6%, 7% Ficoll-70-70
The 5%, 6% and 7% Ficoll-70-70 are typically made by diluting the 10% Ficoll-70-70 to
105
avoid the complications of dissolving the Ficoll-70-70 powder. Usually 100 to 200 ml of
each concentration is made.
D. PBS ++
Important for cell collection step. Add 1 ml of MgCl2 and 1 ml of CaCl2 to 500 ml of
Phosphate Solution Buffer (PBS). Keep refrigerated at 40C
E. Beta-hexosaminidase Assay Start Reagent (200 ml, 0.2 M NaAC, 4mM PNP)
1. Dissolve 3.28 g NaAc (MW= 82.03g/mol) in 150 ml of MilliQ water.
2. pH 5.4 with HAc.
3. Warm until 500C then dissolve 274.4 mg of PNP (MW=342.4 mg).
4. Fill up to 200 ml and store in Refrigerator (40 C).
F. Beta-hexosaminidase Assay Stop Reagent
Make 2M Glycine, pH10 by:
1. Dissolving 75.07 g Glycine (MW = 75.07) in 450 ml of MilliQ water.
2. Then pH to 10 with NaOH.
3. Fill up to 500 ml and store in Refrigerator (4°C).
G. Substrate for Horse Radish Peroxidase Assay
It is preferable to make the reagent a few hours to immediately prior to performing the
assay as the reagent is degrades easily. To retard the degradation process, cover the test
tube containing the HRP reagent in foil. When the reagent turns yellowish like a straw
color, it is no longer suitable for use.
HRP Reagent 15 ml 25 ml 50 ml Final Conc. Storage
10 mg/ml o-dianisidine 150 jl 250 gl 500 jl 0.342 mM in - 80
3% H20 2  1.5 jtl 2.5 tl 5 [l 0.003% v/v in fridge
0.5 M NaPi pH 5.0 1.5 ml 2.5 ml 5 ml 50 mM in fridge
10% Triton 0.45 ml 0.75 ml 1.5 ml 0.3% v/v on shelf
deionized water 13.05 ml 21.75 ml 43.5 ml -- --
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Appendix 4 - Assays
A. Beta-hexosaminidase (p-hex) Assay - used for detecting lysozymes and therefore,
indicates the location of the lysosomes.
1. Transfer 60 pl of each sample being tested to a new 96 well plate.
2. Make P-hex start master mix. Number of wells needed = ( )
Start =( )* 150 [l=
Triton=( )* 3 pl=
3. Add 153 p1l of master mix to each well, mix with pipette.
4. Replace lid and incubate for 2 hour at 37"C.
5. Add 90 pl of stop reagent and wait a few minutes.
6. Pop any large bubbles with a needle and read absorbance(s) at 405 nm.
B. Horseradish Peroxidase (HRP) Assay - used for detecting presence of
HRP and therefore, indicates the location of the late and early endosomes.
1. Transfer 100 pl of the sample.
2. Add 200 pl of the HRP reagent to each well using the multipipetter. Mix well.
3. Replace lid and cover the entire plate with foil to keep the reaction in the dark.
4. Incubate at room temperature until orange color appears,
5. Pop any large bubbles with a needle and read absorbance(s) at 455 nm.
C. Bicinchoninic acid (BCA) Assay - used for detecting total protein levels
1. Transfer 40 pl of each sample and add 60 ptl of water
2. Make BCA reagent. Number of wells needed = ( )
50%A =( )* 100 gl =
48%B =( ) 96 pl =
2%C =( )*4pl =
3. Add 200 pl of BCA reagent to each well, mix well with the pipette.
4. Replace lid and incubate for 2 hour at 37"C.
5. Pop any large bubbles with a needle and read absorbance(s) at 562 nm.
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Appendix 5 - DGE Run Checklist
DGE DATA SHEET #
DGE performed on: Total plates: Gene Delivery: Dyes Ono
Performed by: % confluence: Polymer:
Perfusion Viability: Media: Time Pt:
Perfusion Density: DGE Buffer: DNA/plate:
# cells/plate: Pulse-Chase: Dyes Ono N/P ratio:
Comments:
How do the cells look?
* Pulse Chase:
Pulsed min Chased min Pulse min
* Lysis:
Incubated on Ice min
Lysed with G inch needle with _ pumps (_ counts up, counts down)
Nuclei in 10 tl: Whole Cell in 10 al:
* PNS total protein:
PNS volume = ml (after taking 400 la for whole cell and 250 9l1 for PNS
aliquots)
PNS protein concentration: _ g for l_ (typically 10 dl)
Total Protein in PNS = mg
* Trypsinization
Trypsin added: _ .l (usually 25 gl for each mg of protein)
Incubated in water bath for min (typically 6 min)
Trypsin inhibitor added: _ ll (usually same volume as trypsin)
* Protease Inhibitors
Final volume = PNS + trypsin + trypsin inhibitor + PBS buffer = (typically 8100 gil)
1 mM PMSF (stock=0.2 M) 4 0.005 * final volume = (typically 40.5 pl)
2.5 jig/ml Aprotinin (stock=2.5 mg/ml) 4 0.001 * final volume = (typically 8.1 gil)
10 p.g/ml Leupeptin (stock=5 mg/ml) 4 0.002 * final volume = (typically 16.2 pLl)
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DGE
1. # of fractions collected:
2. Current was reversed for
ASSAYS
1.
2.
Average volume of fraction:
minutes
Volume of HRP Reaction Mix used: (typically 200 [dl)
Incubation time for HRP assay: (typically 2 hour)
CHECKLIST FOR ALIQUOTS
O 400 pl Whole Cell
o 250 pl PNS
O Nuclear pellet
0 150 p1l organelle pellet
O PES
0 Plate of DGE fractions
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Appendix 6 - Sample Preparation Protocol
PREPARATION OF CELL SAMPLE FOR DGE
Date:
Performed by:
Perfusion Viability:
Perfusion Density:
Media:
# Petri dishes:
# cells/dish:
% confluence:
DGE Buffer:
Pulse-Chase: Dyes Ono
Gene Delivery: Dyes Ono
Polymer:
Time Pt:
DNA/plate:
N/P ratio:
CHECKLIST
1. If doing pulse chase, make 1.5 ml (per 60 mm dish) of 2 mg/ml HRP in HGM in a
centrifuge tube. Warm in 370C water bath along with a centrifuge tube of 5 ml of HGM in.
2. If doing a transfection, make 2 ml (per 60 mm dish) of 5 tg/ml total DNA in HGM in a
centrifuge tube. Pre-warm 2 ml of media in 370 C water bath before making the NV
complexes.
3. Put rotor in cold room
4. Turn on ultracentrifuge (upstairs 6th floor Essigman Lab). Set to 20 C and turn on vacuum.
5. Turn on centrifuge in BPEC and set on fast cool (for PNS spin).
6. Check the cells under the microscope at 10x for debris and confluence.
Comments:
7. Gather the following materials:
DO PBS++ and DGE buffer
(keep on ice)
O Cell scraper
O Ice bucket with ice
O Syringe and needle
O Ice tray for washes and media
changes
PULSE-CHASE-PULSE LABELING (OPTIONAL)
* Keep dishes on ice at all times when performing washes and media changes
1. Wash the dishes lx with 3 ml cold PBS++.
2. Label cells for 4 min with 1.5 ml of warm HRP labeled HGM.
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3. Recollect HRP medium into centrifuge tube and return to water bath.
4. Wash the dishes on ice lx with 3 ml cold PBS++.
5. Chase for 15 min with 3 ml of warm unlabeled HGM.
6. Start setting up DGE Device in cold room during your free time.
7. Wash the dishes on ice lx with 3 ml cold PBS++.
8. Label cells for 3 min with 1.5 ml of warm HRP labeled HGM.
9. Recollect HRP medium into centrifuge tube and return to water bath.
CELL COLLECTION
1. Wash cells 2x with 3 ml cold PBS++.
2. Wash cells lx with 3 ml cold DGE.
3. Scrape cells with hard plastic scraper in 2 ml cold DGE buffer
4. Collect in pre-chilled centrifuge tube.
5. Re-scrape uncollected cells in 1 ml cold DGE buffer and collect in same centrifuge tube.
6. Check plate for cells and nuclei. Comments:
LYSIS
1. Resuspend cells by gently tapping the tube against a hard surface.
2. Incubate on ice for 20 min, gently re-suspend pellet every 5 min.
3. Prepare pre-chilled Eppendorf tubes if gene delivery was performed to collect cell fraction
aliquots.
4. Lyse with 21G x 2 inch needle with 12 pumps (8 counts up, 8 counts down) with needle tip
at wall.
5. Inspect 10 pl in microscope on hemacytometer. # Nuclei: # Whole Cell:
Comments:
6. Save 400 pl of lysate as "whole cell" for DNEasy/ PCR in pre-labeled, pre-chilled Eppendorf
tube.
7. Centrifuge 15 min at 2500 rpm to collect nuclei (In the meantime, prepare BSA assay).
8. Remove the supernatant (PNS) with a pipette. PNS volume = [l
9. Save 250 pll of PNS for DNEasy/PCR in pre-labeled, pre-chilled Eppendorf tube.
10. Label tube and freeze nuclear pellet for DNEasy/PCR.
PROTEIN ASSAY
1. Prepare 1.5 ml protein assay reagent (50% A, 48% B, 2% C 4 750 gl A, 720 gl B, 30 l1 C).
2. Make BSA standards (0, 2, 4, 6, 8, and 10 gg) by using 0-5 ul of 2 mg/ml BSA, prepare in
duplicate.
3. Use _ pl of PNS (usually 10 gl).
4. Add filtered water for final volume of 100 gl in each well.
5. Add 100 p.l reagent to each well and incubate for 10 min for at least 10 min at 370C.
6. Once most diluted sample is purplish, read the plate at 562 nm in the plate reader. Make sure
the well with 0 gl of BSA is called blank.
7. The PNS protein concentration: pg for _ gl
8. Calculate the total protein in PNS: Total protein in PNS = mg.
TRYPSIN AND PROTEASE INHIBITOR TREATMENT
1. Defrost trypsin and protease inhibitors on ice.
2. Warm trypsin and PNS in 370C water bath for 1 minute.
3. Add _ 1 of 1 pg/pl trypsin and incubate in water bath for 6 minutes. Use 25 ug per
mg of total protein. Trypsin Type: Type 12 A Bovine Pancreas in DGE buffer.
4. Return sample to ice, and add _ gl of 4 p.g/Il trypsin inhibitor ( in -80C freezer, keep
on ice!). Use 4 gg of trypsin inhibitor per for every 1 gg of trypsin (so use same volume).
5. Final volume = PNS + trypsin + trypsin inhibitor + PBS buffer = (typically
8100 p.l)
6. Add roughly 7 mL of cold PBS to the PNS before adding protease inhibitors.
7. Add protease inhibitors at the following final concentrations (final volume typically 8.1
ml)
1 mM PMSF (stock=0.2 M) + 0.005 * final volume = (typically 40.5 1l)
2.5 1g/ml Aprotinin (stock=2.5 mg/ml) 4 0.001 * final volume = (typically 8.1 p1l)
10 gg/ml Leupeptin (stock=5 mg/ml) + 0.002 * final volume = (typically 16.2 pl)
ULTRACENTRIFUGATION
1. Transfer sample to plastic Beckman centrifuge tube. Top off with PBS at or past fill line.
2. Put stopper and cap on and weigh.
3. Make a balance tube with water within 0.001 g of the sample tube.
4. Place tubes in the Beckman Ti 70.1 rotor and screw on the top firmly.
5. Centrifuge for 1 hour at 100,000 g at 40 = 40,000 rpm.
6. Set up the DGE device in the cold room during the spin time.
NOTES
1. Total protein above 1 mg prevents adequate separation of organelle peaks. Aim to load
an organelle pellet that has around 800 gg of total protein.
2. For best cell collection: press hard on the cell scraper while turning the Petri dish over
720 degrees in a continuous motion so that you accumulate a band of cells on the scraper.
Then move the scraper to the center to scrape the cells in the middle in one continuous
motion. Then "vibrate"/move quickly from side to side in the DGE buffer to coax the
bands of cells off the scraper.
CHECKLIST FOR ALIQUOTS
O 400 jtl Whole Cell
OE 250 gtl PNS
0 Nuclear pellet
0 150 .l organelle pellet
0 PES
O Plate of DGE fractions
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Appendix 7 - DGE Setup and Run Protocol
DENSITY GRADIENT ELECTROPHORESIS DEVICE SETUP
ASSEMBLING THE COLUMN
1. Clear, clean and level the table using the bike pump and level (from the toolbox).
2. Take the DGE column and DGE base out of the soap (no chlorine groups!) solution.
Rinse well with de-ionized water and gently dry with KimWipes and compressed air.
3. Cut a square piece of cellophane (7 cm) and soak in de-ionized water along with the O
ring.
4. After the membrane is soft, fold it into fourths, and cut into a circle.
5. Place the membrane over the opening of the inner column, wetting the column edge with
finger.
6. Using two fingers from each hand spread the O ring over the inner chamber until it fits
into the groove. Make sure that excess membrane is evenly sticking out along the
membrane.
7. Check for leaks with a little bit of water (dry with a KimWipe so it's easier to see if it's
leaking).
8. Grease bottom of the outer column with Vaseline and screw on bottom lid, then place on
the stand in the cold room. (all the rest of the steps are done in the cold room)
9. Connect wire to the palladium cathode (bottom electrode).
10. Connect the syringe to the T shaped tubing.
11. Clamp the short tube and fill syringe with 10% Ficoll-70-70 through the medium length
tube of the T shaped tubing. Push out the bubbles from the syringe and tubing.
12. Tighten the C-clamp about halfway up the longer outlet tube.
13. Then unplug the short tube and push 10% Ficoll-70 to fill the short tube.
14. Flick the T connector while holding the short tube end to get all of the air from the
connector to the top of the short tube.
15. Push the 10% Ficoll-70 to the end of the short tube and connect it to the DGE device's
lower chamber at the bottom inlet (don't put the short tube completely onto the entire
length of the inlet stem-just enough to be secure).
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16. Fill lower reservoir with DGE buffer with the three 50 ml empty syringes on the upper
rack.
17. Insert long tubing ends from the pumps into the channels.
18. Slowly fill the inner chamber with about 2-3 ml of 10% Ficoll-70 using the syringe
pump. Adjust the tubing from the syringe pump to make sure there are no bubbles.
19. Then fill separation column with 10% Ficoll-70 to the top using a pipetter.
LAYING THE LOWER GRADIENT
(Do JUST BEFORE LOADING THE SAMPLE, WILL TAKE 5-10 MIN)
1. Wipe a little bit of Vaseline around the lip of the top cone and screw on the top cone.
2. Slowly maneuver the gradient mixer so that its tubing connects to the top cone and there
are no kinks in the connecting tubing.
3. Secure in place using the PMMA holder and the screw.
4. Slowly infuse 10% Ficoll-70 into the top cone at 3 mL/min and into the tubing of the
gradient mixer until it is flush with the floor of the mixing chamber.
5. Fill right leg with 3.5 ml of 7% Ficoll-70 and clamp the tube between the legs using the
blue clamp when the fluid rushes into the tube (making sure there are no air bubbles).
Put any 7% that rushed into the left leg back into the right leg.
6. Slowly fill the left leg with 3 ml of 10 % Ficoll-70. (left leg is one connected to the DGE
device)
7. Slowly insert stirrer and plug in, let the solution start stirring, with the power source at 6
V and then unclamp the blue clamp.
8. Slowly loosen the metal clamp until the solution is dripping into the 10% Ficoll-70
container at an approximate rate of 1 drop per second. Adjust the clamp at times to
maintain a steady flow rate
9. Run the gradient mixer until the entire gradient enters the column and the level of the
solution inside the column is about one third of the way down the cone (to leave enough
room for sample loading). Then tighten the metal clamp on the outlet tube.
10. Disconnect the stirrer and slowly loosen the PMMA holder to carefully free the gradient
mixer. Balance on two of the three legs of the gradient mixer and slowly lift at an angle.
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11. Put up warning sign on the door of the cold room - asking people to open/close carefully
and to mind the vibration sensitive experiment.
12. Wash the gradient mixer and stirrer with de-ionized water. Dry with KimWipes &
compressed air.
APPLYING THE SAMPLE
1. Collect the Post Endosomal Supernatant (PES) in an eppendorf tube and keep for PCR.
Resuspend the pellet in 650 ltl of cold 6% Ficoll-70-70 in DGE Buffer with a 21G x 2
syringe. Break up the pellet a bit more gently than the during the lysis step.
2. Transfer to pre-labeled, pre-chilled eppendorf tube and spin at full speed in the small
table top centrifuge for 15-20 seconds to determine success of the re-suspension. Give a
few extra pumps through the syringe if a pellet forms and re-spin to check again.
3. Take up 500 pll for DGE run.
4. Using your left hand, slowly squeeze the T tubing between the T and the column so that
the level inside the inner column rises to the top of the cone.
5. Using your right hand, slowly pipette 500 p• of sample using a P1000 onto the top of the
cone, while letting go of the tubing slowly. Try to match the rate of addition and
downward flow from the release.
6. Save the leftover 150 tl for DNEasy/PCR.
LAYING THE UPPER GRADIENT
1. Slowly maneuver the gradient mixer so that its tubing connects to the top cone. Secure in
place using the piece of PMMA and the screw.
2. Slowly infuse the sample into the inner column of the gradient mixer using the syringe
pump (max speed 2 ml/min) so that the solution inside the top cone enters the tubing of
the gradient mixer and ends just below mixing chamber. Leave the sample roughly 3-4
mm below the bottom of the left leg floor or you will get a mushroom in the sample
band.
3. Carefully fill right leg with 13 ml of DGE buffer (0% Ficoll-70 solution) and clamp the
tube between the legs using the blue clamp, when the fluid rushes into the tube
connecting the two legs.
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4. Fill the left leg with 12.5 ml of 5% Ficoll-70 --- Add very slowly so you don't disturb the
sample band using the 2 ml pipette to add at least the first 2.5 ml (stick the pipette to the
bottom of the gradient mixer column. Add the remaining 5% Ficoll-70 with a 10 mL
pipette-- release it very slowly right at the upper water level and against the wall.
5. Slowly insert stirrer and plug in, let the solution start stirring, with the power source at 6
V and then unclamp the blue clamp.
6. Slowly loosen the metal clamp until the solution is dripping into the 10% Ficoll-70
container at an approximate rate of 1 drop per second.
7. Remember to adjust the clamp at times to maintain a steady flow rate until the entire
gradient enters the column and level of the solution has dropped to the top of the inner
column.
8. The sample should appear in one flat whitish disc. If you get a mushroom the run is
ruined, so perform these steps very carefully.
9. Disconnect the stirrer and slowly loosen the PMMA holder to carefully free the gradient
mixer.
10. Wash the gradient mixer and stirrer with de-ionized water. Dry with KimWipes &
compressed air.
FILLING THE TOP CHAMBER AND STARTING THE RUN
1. Carefully remove the top cone. Place metal sieve on top of the inner column
2. Turn on the syringe pump at 2 mL/min until the top gradient wets the sieve.
3. Using one or two syringes + tubes, carefully fill the upper chamber with DGE buffer until it
reaches the bottom of the horizontal outlet. Squeeze the tubes slightly to slow down the
filling rate when the water level approaches the sieve and covers it.
4. Slowly remove the metal sieve without disturbing the contents of the inner chamber
5. Slowly pivot the upper electrode (platinum cathode) into the top chamber and secure in place
with the PMMA holder.
6. Turn on the pumps to circulate the DGE buffer in the lower chamber. Put 400-500 ml fresh
DGE buffer in the recycling beaker.
7. Turn on ammeter to read current. Turn on the power supply. Set to "constant current mode".
Time= 80 min, Voltage = 300V, Current = 1 imA, unless otherwise specified:
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8. During the run, wipe top electrode with paper clip to get ride of bubbles every 10 minutes.
9. Check that the current is around 10.5-10.7 mA.
ENDING THE RUN AND COLLECTING THE SAMPLES
1. Turn off the pumps, power source, and amp-meter.
2. Slowly unscrew the upper electrode and remove from the top chamber. Slowly replace the
metal sieve, entering the upper buffer chamber at an angle to prevent large disturbances.
3. Using a syringe and tubing, suck up DGE buffer and dispose in Erlenmeyer waste flask.
4. Loosen brown clamp and allow for about 20 drops to leave the column, so that the level of
the solution inside the inner chamber comes below the metal sieve.
5. Remove the metal sieve, then screw on top cone again (with thin tubing already attached).
6. Screw in the long PMMA arm with the same screw as before and thread tubing through the
hole on the long arm, adjust tubing height accordingly over the box and collection plate.
7. Infuse at rate of 2 ml/min to fill the cone and tubing, then the flow rate can be switched to 3
mL/min. Collect 24 fractions from the end of the thin tube in the 96 deep well plate
(average volume of fraction = 1.25 ml ).
8. Mix the 2 rows of samples at least 10 times with a multichannel pipette set to 200 Al. Next
take 200 All of the mixed samples out and add to a DNEasy collection plate for storage before
DNA purification. Freeze this plate along with the original deep well collection plate, which
will provide material for b-Hex assays and backup samples.
9. Switch input at the power supply, take off top cone, fill upper chamber with buffer and put
the short holder back on to secure the upper electrode.
10. Run for the same amount of time in reverse current mode in order to recharge the palladium
electrode.
11. Current was reversed for minutes.
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Appendix 8- Overview of DGE Runs
Set One: Initial Results, Spring and Summer 2004
Much of the early DGE runs were for practice and also for testing variations on the protocol such
as testing the length of culture time or comparing wet versus dry collagen monolayers. The cell
suspension results were compared to culture cell results to compare the viability of the cells; the
cell suspension samples being the control because the DGE was done directly on freshly
perfused cells rather than on cells that sat in a Petri dish overnight. Most of these DGE runs of
the cultured cells had a seeding density of 4 million cells on 10 cm Petri dishes. Simple assays
revealed good separation of early and late endosomes
# Date # of Fraction Comments
1 03/20/04
2 04/16/04 92 no datasheet
3 05/18/04 72 no datasheet
4 05/25/04 96 270 gl took 2 million cells directly from perfusion
5 05/28/04 96 220 pl - 96
6 05/29/04 -- loading error...bad DGE run
7 06/22/04 96 3 million cells in suspension
8 06/23/04 96 started drying collagen monolayer
9 06/26/04 96 4 M 24 hr
10 06/29/04 96 270 gl : 4M 24hr: testing culture time
11 06/30/04 107 270 gl: 4M 48hr: testing culture time
12 07/01/04 96 270 gl : 4M 72hr: testing culture time
13 07/07/04 84 390 pl1 - 84: 4M 24hr: testing culture time
14 07/08/04 86 380 gl - 86: 4M 48hr: testing culture time
15 07/09/04 96 380 l1 - 4M 72hr: testing culture time
16 07/15/04 Probably a run for Western blotting
Set Two: Modifications, 2005
With such promising results, optimizing the DGE process was set aside to work on setting up
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Western Blotting analysis of the frozen fractions from the first batch of DGE. It wasn't until
nine months later that DGE testing resumed. The first major modification involved a change
from 10 cm Petri dishes to 60 mm dishes. Soon after, fractions were collected in the larger 96
well plates that could hold approximately 1.2 ml in each well. Lastly, this set of DGE runs
began to test the effects of gene vectors.
# Date # of Fraction Comments
17 04/12/05 started using 2.25 million cells on 60 mm dishes
18 05/07/05 24 hr
19 05/08/05 72 hr
20 05/18/05 15 min GD PEI25 N/P20 15 jtg DNA in 3 tl AFM
21 06/11/05 24 not sure what it was used for
22 06/18/05 24 2 hr GD PEI25 N/P20 15 jig DNA in 3 tl AFM, no datasheet
23 06/23/05 two plates, comparing DGE to PBS????
24 06/29/05 30 used 2.5 million
24.5 06/30/05
25 07/08/05 34 2 hr GD PEI25 N/P20 15 gg DNA in 3 jtl AFM, washed @ 100'
26 07/09/05 36 1 hr GD PEI25 N/P20 15 jg DNA in 3 tl AFM, washed @ 50'
40min GD PEI25 N/P20 10 jig DNA in 3 jl AFM, no pulse-
27 09/08/05 24 chase
28 10/22/05 used 6 well plate, .075M/cm2
29 11/30/05 Probably a run for precipitation purposes
Set Three: DGE Runs for Western Blotting, 2006
The third set of DGE runs was devoted to accumulating enough material for Western Blotting.
These runs did not have gene delivery. A quick HRP assay was performed to determine the
location of the early endosomes and late endosomes, and the fractions were pulled for dialysis or
ultracentrifugation. The HRP assay results were similar to the graphs above. The run details are
described in Appendix 9. See Chapter 6 for more information.
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# Date # of Fraction Comments
30 01/28/06 pulse but no chase, just testing dialysis to see if it works
31 02/01/06 pulse but no chase, just testing dialysis to see if it works
32 02/04/06 24 messed up gradient =(
33 02/07/06 30 used for dialysis
34 02/18/06 bad gradient, peaks did not separate
35 02/25/06 repeat of above using 2 plates (one w/HRP, one w/o) for dialysis
36 03/09/06 x no DGE, just lysis to test double ultracentrifugations
two plates, spun in ultracentrifuge first plate: EE 20-24, LE 9-14,
37 03/15/06 second plate: added EE
Set Four: DGE Runs with Gene Delivery
The fourth and current set of DGE runs has the largest number of runs. These are mostly DGE
runs on various time point s for gene delivery of the new generation C32-7 and X-linked vectors
as well as preliminary runs on adenovirus. These vectors did not significantly affect the
separation. The results are briefly described in Chapter 7. A few DGE runs were also
performed on the HepG2 cell line with and without gene delivery.
# Date # of Fraction Comments
38 03/18/06 24 C32-7, 40 min
39 03/21/06 24 C32-7, lhr
40 03/21/06 x C32-7, 4 hr -- did not do DGE
41 03/21/06 x no GD, did not do DGE either...just for control
42 03/22/06 24 C32-7, 2 hr
43 03/23/06 24 C32-7, 20 min, 2 plates combined
44 04/06/06 24 C32-7, 20 min, just one plate
45 04/11/06 24 C32-7, 10 min
46 04/13/06 24 C32-7, 1 hr
47 04/19/06 24 C32-7, 40 min
48 04/20/06 pulse chase on HepG2
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49 04/25/06 24 C32-7, 20 min, morning
C32-7, 20 min, to test whether it was the cell culture time or GD
50 04/25/06 time that affected lysis
51 04/27/06 24 C32-7, 20 min in morning
52 04/27/06 24 C32-7, 10 min in afternoon
53 04/28/06 24 C32-7, 40 min in morning
54 04/28/06 C32-7, 2 hr in afternoon -- lysis looked bad, repeat next week
55 05/02/06 24 C32-7, 2 hr in morning
56 05/04/06 24 C32-7, 20 min in morning on HEPG2
57 05/04/06 24 C32-7, 40 min in afternoon on HEPG2
58 05/13/06 24 X-linked, 20 min
59 05/24/06 24 X linked, 10 min morning
60 05/24/06 X linked, 40 min afternoon - sample froze in centrifuge
61 05/27/06 24 X linked, 40 min morning
62 05/27/06 24 X linked, 1 hr afternoon
63 06/07/06 no GD, and no DGE -- scrapped because froze PNS
no GD, bad mushroom on DGE, did not collect (probably
64 06/07/06 because too much protein)
65 06/15/06 24 X linked, 10 min morning
66 06/15/06 x linked, 20 min afternoon -- need to redo, ugly mushroom
67 06/16/06 24 X linked, 40 min morning
68 06/16/06 24 X linked, 2 hour afternoon
69 06/20/06 24 X linked, 20 min morning
70 06/20/06 X linked, 1 hour afternoon
71 06/27/06 24 Background
72 06/29/06 24 X linked, 2 hour
73 07/06/06 24 X linked, 1 hour
74 07/11/06 adenovirus, 40 minutes, no DGE because ultracentrifuge broke
4 plates --> 0.8 mg of protein per spin/DGE --> for
75 07/13/06 ultracentrifuge and westerns
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Appendix 9- Materials Needed for SDS-PAGE, Western Blotting, and Precipitation
catalog # Description Amount Price
Amersham Biosciences
RPN2135 ECL Advanced Western Blotting Detection Kit
BD Biosciences
610456 Mouse anti-EEA1 mAb IgGI (250 jig/ml)
BIOWORLD Call 1-888-bioPLUS
Bio Orbit rocker ( 20x20 in, +/- 42 degrees, 0-
AR-100-20 100 rpm, 110 AC, 2 amps)
BioRad Laboratories (100018) Call 1-800-4-BIORAD
165-3365 10 well, 1.5 mm combs
161-1154 7.5% Tris-HCl Ready Gel (10 well, 50ul)
161-0374 Protein Standard (50 applications)
162-0174 PVDF Membrane (7x8.4 cm)
161-0300 SDS
162-0184 Sequi-Blot PVDF Membrane (24 cm x 3.3 m)
165-3308 short glass plates
165-3312 spacers 1.5 mm
50 jtg or 0.2 ml
1 rocker
2 combs
1 plate
500 gtl
10 sheets
25 g
1 roll
5 plates
5 plates
Cole Parmer
00149YG
EW-02898-
63
http://www.coleparmer.com/
SPECTRA/GEL ABSORBENT:
Polyacrylamide Condenser
Spectra/Por® Float-A-Lyzer TMDialysis Tubes
500G
5 ml, 100 K
MWCO
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$1,031.23
$22.00
$8.50
$105.00
$55.00
$15.00
$275.00
$17.00
$45.00
$58.00
$74.70
National Diagnostics (100602) http://www.nationaldiagnostics.com
EC-890 Protogel
EC-892 Protogel Resolving Buffer
EC-893 Protogel Stacking Buffer
EC-886 Sample Loading Buffer
EC-503 TEMED
EC-504 Ammonium Persulfate
HS-604 Coomassie Blue R-250
EC-603 2-Mercaptoethanol
EC-870 10x Running Buffer (Tris-Gly-SDS)
EC-604 SDS
Perkin Elmer
8701302001
EA
NEL104001
EA
Santa Cruz
sc-26571
sc-6562
sc-6486
sc-2768
sc-2922
Life Sciences (102428) http://www.perkinelmer.com
BioMax® MR-1 Autoradiography Film,
20.3x25.4cm 50 sheets
Western Lightning® Western Blot
Chemiluminescence Reagent Plus For 2500
cm2 Membrane. 170 ml each
Rab 5C (C-13) 200 glg/ml
Rab 9A (C-18) 200 jig/ml
Cathepsin D (C-20) 200 gg/ml
Rabbit Anti-Goat HRP 200 jig in 0.5 ml
Rabbit Anti-Goat HRP preadsorbed 200 jig in 0.5 ml
Sigma-Aldrich (100011) Call 1-800-365-2535, Pin # 349220
S6191 Sodium Chloride
274348 Tween-20
P8340 Protease Inhibitor (AEBSF, Aprotinin,
500 G
500 ML
5 ML
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(1 L)
(1 L)
(200ml)
(lml)
(25 ml)
(100 g)
(10 g)
(50 ml)
(4L)
(1 kg)
$78.00
$37.00
$15.00
$16.50
$15.75
$23.00
$16.50
$15.75
$50.00
$123.50
$188.00
$209.00
$230.00
$230.00
$230.00
$60.00
$85.00
$29.70
$20.80
$141.20
leupeptin, bestatin, pepstatin A, E-64)
Phenol Red Concentrate
Alpha-toluenesulfonyl fluoride (PMSF)
Ponceau S
Hepes
Trichloroacetic acid solution 6.1 N
Scientific Corporation
SAMCO transfer pipettes
arket
Shaw's Non-Fat Dry Milk (9.6 oz, 272g)
VWR Scientific Products (102389)
PI28324 Surfact AMPS NP-40
MK301606 Methanol
21427-364 Chromatography Paper 20x20 cm
EM-6505 10x PBS
11214-301 Kapak 4x6" Sealable Pouches
MK758106 NaCl
Sorenson Biosciences: Multiflex Round Tips
(RNase/DNase free, non-pyrogenic, ID=0.5
13790 mm, 200 ýtl)
15155-014 Film Cassette (20x25 cm)
60 ML
IL
100 sheets
4L
100 pouches
2.5 kg
1 tip box
1 cassette
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P8421
P7626
P3504
54457
T0699
Samco
202
Star M
2 ML
25 G
10G
100 ml
$15.20
$153.00
$12.20
$29.80
500
1 box -$5.00
$79.00
$34.02
$36.17
$54.48
$9.30
$16.94
$130.00
Appendix 10 - SDS-PAGE and Western Blotting Solutions
5 ml of 2X sample buffer (store at -80 'C in 1 ml aliquots)
* 0.625 ml 1 M Tris, pH 6.8 (125 mM)
* 1 ml 20% SDS (4%, or 0.2 g)
* 1 ml glycerol (20%)
* 0.1 ml 1% bromophenol blue in 10% EtOH (0.02%)
* Optional: Add 200 mM DTT = 0.1542 g or 10% BME if needed for reducing conditions
* Fill to 5 ml with H20 (-2.275 ml)
2 L of 1X TGS running buffer (store at room temperature)
* 5.8 g Tris base (240 mM)
* 28.8 g Glycine (1.9 M)
* 2gSDS
* Volume to 2 L with MilliQ water (don't pH)
2 L of 2x Transfer Buffer without MeOH (Store at room temperature)
* 5.8 g Tris base (12 mM)
* 28.8 g Glycine (100 mM)
* 2 ml 20% SDS
* Volume to 1.8 L with MilliQ water (don't pH)
1 L of lx Transfer Buffer with MeOH (Make fresh, do not store)
* 450 ml of 2X Transfer Buffer
* 450 ml of MilliQ water
* 100 ml of MeOH
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TBS-Tween (Stable for weeks at room temperature although Tween can oxidize)
* 40 ml 1 M Tris-HC1, pH 7.5 (20 mM)
* 54.8 ml 5 M NaCl (137 mM)
* Volume to 2 L with H20, then add:
* 2 ml Tween (0.1%, Fisher Scientific-for TBS just omit this)
Coomassie blue staining solution
* 0.1% w/v Coomassie blue R250
* 40% MeOH
* 10% HAc
Destaining solution
* 30% MeOH
* 10% HAc
Lysis Buffer (use 100 pl per million cells)
* 1%0.1MPMSF
* 10% protease inhibitor cocktail
* 89% HNN solution
o 10 mM Hepes (pH 7.6 in distilled water)
o 150 mM NaCl
o 1% NP40
Blocking Solution (make fresh for each SDS-PAGE run)
* 5 g Carnation Milk Powder
* 100 ml of TBS-T
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Appendix 11- Lysis Buffers
DAL Lab's Lysis Buffer
Final Concentration. Ingredient Amount to add for 10 ml
Solutions stored at 4 "C
-- ddH 20 5.665 ml
50 mM 0.5 M f3-glycerophosphate, pH 7.3 1 ml
10 mM 0.1 M NaPP 1 ml
30 mM 0.5 M NaF 0.600 ml
50 mM 1 M Tris, pH 7.5 0.500 ml
1% 20%: Triton X-100 0.500 ml
150 mM 5 M NaC1 0.300 ml
1 mM 100 mM benzamidine 0.100 ml
2 mM 500 mM EGTA 0.040 ml
Solutions stored at -20 'C
100 ýtM 40 mM sodium orthovanadate 0.025 ml
1 mM 500 mM DTT 0.020 ml
Sensitive Items stored at -20 'C
10 [ig/ml 5 mg/ml aprotinin 0.020 ml
10 [ig/ml 5 mg/ml leupeptin 0.020 ml
1 gg/ml 1 mg/ml pepstatin 0.010 ml
1 gtg/ml 1 mg/ml Microcystin 0.010 ml
Sensitive Items stored at 4 'C
1 mM 50 mM PMSF 0.200 ml
Alexandria's Lysis Method
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1. To make lysis buffer, make 10mM Hepes pH 7.6 and 150mM NaCi in MilliQ water and
autoclave before adding NP40 (1% final concentration).
2. Add the Sigma protease inhibitor cocktail at 1:10 (v/v) and PMSF (0.1M final
concentration) just before use. The lysis buffer should be ice cold.
3. 100 pld of lysis buffer is added for every million cells. This would thus include 1 pl1 of
PMSF, 10 pl of the Sigma protease inhibitor cocktail, and 89 pl of the Hepes, NaC1, and
NP40 solution.
4. The whole cells and lysis buffer should be mixed with a standard pipette, vortexed, and
incubated on ice for 10 minutes before spinning in a centrifuge at 40C and 10000 rpm for
5 minutes.
5. Transfer the supernatant to a new eppendorf tube. This whole cell lysate can be stored at
-20 0 C for several months.
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Appendix 12 - SDS-PAGE gels
Ref. BIO-RAD ' s " Mini-PROTEAN 3 Cell Assembly Guide"
1. Assemble gel sandwich
a. Place together short and spacer plates so that both places are flush at bottom on a
level surface. Slide the 2 plates into casting frame with the smaller plate-facing
front. Lock pressure cams to secure the glass plates.
b. Place a gray rubber gasket on bottom of gel assembly apparatus.
c. Insert gel cassette sandwich into gel apparatus: Place sandwich on top of gray
casting stand gasket and engage the top of the spacer plate with the spring loaded
lever. Make sure the lever pushes the spacer plate down so both plates are
perpendicular against the gray rubber gasket.
2. 7-15% Stacking Gels
a. Decide on the concentration based on the size of the protein of interest.
* Use 7 or 8% gels for proteins >60 kDa
* Use 10% gels for proteins > 40 kDa such as collagenase
* Use 12% for proteins >25 kDa such as TIMPS
* use 15% for proteins < 25kDa such as IL-1 and PDGF
b. Prepare the separating or resolving gel solution according to the recipe below.
* X ml Protogel (X = desired % final)
* 7.8 ml Protogel buffer
* 30 ul TEMED
* Volume to 30 ml with H20
* Degas if desired.
c. Prepare 500 [l of 10% APS in H20 (APS is stable for 1 week).
d. Immediately before pouring the resolving gel into the gel cassette sandwich, add
300 pl of the freshly-made 10% APS.
e. Swirl gently after APS addition, then use a Pasteur pipette to insert solution
between glass plates up to the bottom of the green bar.
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f. Immediately after adding separating gel, use another Pasteur pipette to add
butanol to the top of gel.
g. Allow about 20 minutes for the separating gel to polymerize. Test by squeezing
the top of the used Pasteur pipette or shaking the centrifuge tube containing extra
separating gel solution: if solution has solidified, polymerization has occurred.
h. When separating gel has polymerized, pour out and wash out butanol in sink with
tap water.
i. While the separating gel is polymerizing, prepare the 4% stacking gel solution.
3. 4% Stacking gel
a. The recipe makes 10 mL which is enough for two 1.0 mm gels. Mix all the
following reagents in 15 ml tube:
* 1.3 ml Protogel (4 % final)
* 2.5 ml Protogel stacking buffer
* 6.1 ml H20
* 10 gl TEMED
* 5 gl 2000x phenol red concentrate (Sigma)
* Degas if desired.
b. Add 50 [l of APS and pour immediately. Then quickly but carefully insert a
1.5mm, 10-well comb between the glasses while making sure no air bubbles are
trapped between the teeth of the comb.
c. Allow 30 minutes for polymerization.
d. When the stacking gel has polymerized, carefully remove comb. Rinse and
irrigate the wells with lx running buffer thoroughly.
* Protogel (National Diagnostics) contains 30% w/v acrylamide, 0.8% w/v bis-acrylamide
* Protogel buffer contains 1.5 M Tris-HC1, 0.384% SDS, pH 8.8
* Protogel stacking buffer contains 0.125 M Tris-HCl, 0.1% SDS, pH 6.8
** Gels can also be purchased ready-made from BioRad **
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Appendix 13 - SDS-PAGE and Western Blotting Protocol
(modified from Alexandria's version)
1. Gel Rig Assembly & Sample Preparation
a. Assemble gel rig with shorter plates facing inside as according to the Bio-Rad
protocol. If running only one plate, be sure to use the buffer dam.
b. Add running buffer (IX TGS) to inside compartment of the gel rig until the buffer
overflows and outside compartment is filled to about one centimeter below the
height of the longer plates. This way the temperature along the gels stay
stabilized during the electrophoresis.
c. Turn on the heat block (100C).
d. Add equal volume of 2x sample buffer to samples and positive control if sample
buffer not yet added. Each well can load 50 pl of sample.
e. Boil samples on heat block for 3 min (Hint: Add plastic caps so tube tops don't
pop off).
f. Meanwhile, carefully remove the combs from the gels and using a plastic pipette,
wash the wells with the running buffer.
2. Gel Loading and the Run
a. Load 5ul of pre-stained Molecular Weight standard.
b. Load up to 50 [il of each sample, including negative and positive controls.
c. Run gel at 100V for approximately 1.5 hours @ room temperature until the dye
front has reached the bottom of the gel.
3. Western Blotting
a. Five to ten minutes prior to the SDS-PAGE run ends, make the transfer buffer and
soak pre-cut transfer membrane in 100% methanol for a few minutes until the
entire membrane is translucent. (Note: always handle membrane with gloves or
forceps to prevent contamination).
b. Then transfer the PVDF membrane into the transfer buffer 1.
c. Add 2 pieces of thick Whatmans to the transfer buffer container 2.
d. Place blotting apparatus in transfer buffer with the clear face down.
e. Add a sponge to the clear face and massage out any air bubbles.
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f. Lay 1 thick pre-soaked Whatman on the blotting apparatus and then lay the PVDF
membrane in the center on top of the Whatman, making sure that there are no
bubbles between the two.
g. Disassemble the gel by removing the smaller plastic plate (the gel should remain
stuck to the larger plastic plate). Cut off top portion of the gel, where the well
lanes and the stacking gel are.
h. Carefully place the gel on top of the membrane. The lower the percentage of
polyacrylamide in the gel, the easier the gel will break.
i. Smooth out the bubbles carefully with your gloved finger or a flat headed
instrument.
j. Optional: Use a waterproof pen or pencil to mark the position of the standards on
the membrane (they don't always transfer).
k. Place the other thick Whatman on the blotting apparatus. Make sure it is flush
with the other Whatman.
1. Add the second sponge and close the sponge rack.
m. Place the sponge rack in the transfer chamber (pre-filled with transfer buffer).
(Note: The black side of the sponge rack faces the black electrode.
n. Place the transfer apparatus on top of a stir plate in the cold room.
o. Run the transfer 1 hour at 100V at 40 C (Note: 2h at 40V, or overnight at 20V at
4'C also works).
4. Blocking
a. Cut off the corner of the membrane for orientation and keep the membrane
protein side up throughout subsequent steps.
b. Remove the membrane from the transfer apparatus and rinse in PBS. Note: The
gel can be stained in Coomassie or the membrane can be stained with Ponceau S
to ensure transfer has occurred.
c. Place membrane in - 30 mL Blocking Solution 1 hour at room temperature on the
rocker.
d. Wash membrane three times in approximately 20 to 30 ml TBS-T 5 minutes each.
5. Optional: Coomassie Stain
133
a. For the Coomassie stain (Coomassie dye dissolved in methanol, glacial acetic
acid, & water) allow it to incubate for at least 1h-overnight (for low MW
proteins).
b. Destain the gel in the previously mentioned solution without the Coomassie dye.
This leeches out the stain to clear the background and leave stained protein bands
that can be visualized and photographed.
6. Primary Antibodies
a. Place membrane heat-sealable bag.
b. Add the 40 gtl primary antibody to 10 ml TBS-T making a 1:250 dilution.
c. Seal bag and nutate the membrane overnight at 40 C, then empty the contents into
a small tray, slightly larger than the blot itself and designated for primary
antibody incubation, and incubate for an additional 1 hour at room temperature on
the rocker.
7. Secondary Antibodies
a. Wash membrane three times in approximately 20 to 30 ml TBS-T 5 minutes each.
b. Place membrane in a second plastic container, designated for secondary antibody
incubation.
c. Add the 12 Vl HRP-conjugated secondary to 30 ml of the blocking solution (5%
milk powder in TBS-T) making a 1:2500 dilution.
d. Incubate at room temperature for 1 hour on the rocker.
8. Visualization
a. Wash membrane three times in approximately 20 to 30 ml TBS-T 15 minutes
each. This higher wash time is to compensate for the higher antibody
concentrations.
b. Mix equal volumes of visualizing reagents 1 and 2 together (1 to 5 ml each) in a
15 ml centrifuge tube.
c. Pour into the container designated for the visualizing reagent and put the
membrane face down onto the reagent. Incubate for at least one minute.
d. Visualize on the Kodak Electronic Developer.
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Appendix 14- Precipitation Protocols
I. TCA precipitation
1. Add enough TCA to make 10% TCA in sample
2. Incubate on ice for 30 min to 1 hour
3. Centrifuge full speed at 4C for 15 min
4. Decant supernatant.
5. Add 45 [l of lx reducing sample buffer
6. Add 2M Tris until the solution is purple again
7. Boil 3 minutes and load
II. TCA in acetone
1. Add 1 volume of TCA to 1 volume of protein solution
2. Add 8 volumes of acetone solution with 0.07% 2-mercaptoethanol
3. Incubate minimum 45 min at -20C
4. Centrifuge 20 min, 4C, max speed
5. Wash 2x with acetone w/0.07% 2-mercaptoethanol (spin at max speed, 4C, 5 min)
6. Air dry
III. Ethanol only
1. Add 9 volumes of cold 100% ethanol to 1 volume of sample and vortex
2. Incubate in -80C for >2 hours
3. Microfuge for 30 min at 12-14,000 rpm at 15-20C
4. Carefully air dry
IV. Acetone only
1. Add 4 volumes of cold acetone to 1 volume of sample and vortex
2. Keep 10 min at -70C and at least 90 min in -20C
3. Spin 15 min at 4C in microfuge at max speed 15,000 G
4. Carefully discharge sup. Dry via speed-vac or dry air to eliminate acetone residue
(smell tubes)
5. resuspend in sample buffer
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V. Large Scale TCA/Acetone Precipitation
1. Mix the following solutions in a 1:8:1 ratio in the following order (invert tube after
adding each component):
i. 1 ml cell lysate
ii. 8 ml 100% ice-cold acetone
iii. 1 ml 100% trichloroacetic acid (100% TCA)
2. Precipitate at -200 C for one hour.
3. Centrifuge at 11,500 (18000 x g) for 15 min at 40C in a microcentrifuge.
4. Discard supernatant. Wash with 1 ml ice-cold acetone. Centrifuge at 11,500 rpm for
15 min at 40 C.
5. Discard supernatant. Dissolve the protein pellet in the appropriate volume of sample
buffer by repeatedly pipetting up and down to break up the pellet.
6. Allow sample to sit at room temperature for one hour, vortexing approximately every
ten minutes.
7. Transfer to Eppendorf tube and centrifuge at 14,000 rpm for ten minutes at room
temperature. Immediately transfer the supernatant into a new Eppendorf tube.
8. Store at -800 C until ready for use. Discard pellet.
VI. TCA-DOC (for low volume protein concentration)
1. To one volume of dilute protein add 1/100 volume of 2% DOC (sodium
deoxycholate) in ddH20.
2. Vortex and let sit for thirty minutes on ice or at 40C.
3. Add 1:10 volume to volume 100% TCA and incubate overnight at 40C.
4. Centrifuge at maximum speed for 15 minutes at 40C
5. Pour off supernatant and dry pellet with a Kimwipe
6. Wash the pellet twice with starting volume of -20 0 C acetone.
7. Incubate the pellet for fifteen minutes on ice, and centrifuge for five minutes at
maximum speed at 40 C for each acetone wash.
8. Kimwipe the samples and dry the pellets in a fume hood.
9. Add 2x loading buffer and run proteins on a gel
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Appendix 15- Dialysis Ordering Information
Product Numbers for Spectra/Por Float-A-Lyzer with Biotech Cellulose Ester Membranes
MWCO 300 iL 500 IL 1 mL 3mL 5mL 10mL
100 235001 235013 235025 235037 235049 235061
500 235002 235014 235026 235038 235050 235062
1,000 235003 235015 235027 235039 235051 235063
2,000 235004 235016 235028 235040 235052 235064
3,500 235005 235017 235029 235041 235053 235065
5,000 235006 235018 235030 235042 235054 235066
8,000 235116 235118 235130 235142 235154 235166
10,000 235007 235019 235031 235043 235055 235067
15,000 235008 235020 235032 235044 235056 235068
25,000 235009 235021 235033 235045 235057 235069
50,000 235010 235022 235034 235046 235058 235070
100,000 235011 235023 235035 235047 235059 235071
300,000 235012 235024 235036 235048 235060 235072
Price (US$) 74.00 74.00 77.00 77.00 83.00 83.00
Spectra/Gel Absorbent (500 g)
Catalog # 292600
$58.00
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Appendix 16- Spectra Float-A-Lyzer Dialysis Membranes (from Spectrum website)
Spectrum introduces the Spectra/Por Float-A-Lyzer, a dialysis membrane tubing pre-sealed at
one end that attaches to a floatable cap at the other for convenient dialysis of sample volumes of
300 gL, 500 gLL, 1 mL, 3 mL, 5 mL and 10 mL. Each Float-A-Lyzer Dialysis Tube features
innovative Spectra/Por Biotech membranes with thirteen available Molecular Weight Cut Offs
(MWCO) ranging from 100 to 300,000 Daltons for all types of separation applications.
High purity membranes yield excellent recovery for biological samples such as proteins,
peptides, antibodies, DNA, etc. Purifications by removing small molecular weight contaminants,
desalting, buffer exchange and concentration are quick and easy to handle with the Float-A-
Lyzer.
Multiple Float-A-Lyzer's can be simultaneously dialyzed in a single reservoir. Fast and
convenient sample concentration is easy by covering the outside of the Float-A-Lyzer membrane
with Spectra/Gel Absorbent after dialysis. The absorbent powder draws out water and other
small molecules until the desired level of concentration is obtained. Each Spectra/Por Float-A-
Lyzer Dialysis Tube is individually packaged wet in .1% sodium azide preservative. Simply
rinse the dialysis tube in DI water to remove the preservative. Do not boil or soak prior to use.
Float-A-Lyzer is economically priced and is packaged 10/box.
The membranes are usually still functional after they have been frozen. The main mode of failure
is stress cracks in the membrane which can be seen visually or tested by adding water to a small
portion of the membrane. It has been shown that freezing it does change the porosity of the
membranes but only makes it slightly tighter (<10%).
The recommended time for dialysis is usually overnight (-17 hours) with at least 3 buffer
changes. Times may vary depending on different factors (temp., ionic strength of sample, etc.).
The methods for checking depend on the type of molecule that is being dialysed out.
Conductivity or spectrophotometry are a couple of ways that have been used.
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Appendix 17- Spectra/Gel Absorbent for Easy Concentration (from Spectrum website)
* High water absorbent capacity
* Easy to use with any MWCO dialysis membrane
* Easy to concentrate small molecular weight molecules
* Easy to remove
* Cost effective
* Convenient for sample concentration with Float-A-Lyzer, Micro DispoDialyzer and
DispoDialyzer
Spectra/Gel makes the concentration of protein sample solutions quick and efficient. Made of
polyacrylate-polyalcohol it has the property of expanding as it absorbs water. The high molecular
weight polymer can be used with dialysis membranes of molecular weight cut offs (MWCO)
from 100 to 300,000 Daltons without contaminating the sample. After dialysis, simply remove
the dialysis tubing containing the sample and coat it with Spectra/Gel. Water and smaller
molecules diffuse through the membrane and are absorbed by Spectra/Gel Absorbent.
Concentration continues unattended until a certain volume of water is removed from the sample.
The insoluble characteristic makes Spectra/Gel easy to remove after absorbancy.
The length of time needed for concentration will depend on the final volume, the MWCO, the
surface to volume ratio of the membrane tubing and the amount of Spectra/Gel Absorbent. After
dialysis in a Spectra/Por Float-A-Lyzer@ with a 15 kD MWCO can be reduced from the starting
volume 5 mL to 0.5 mL in 60 minutes with 100 grams of the Spectra/Gel Absorbent.
Easy-to-use dialysis products such as Spectra/Por Float-A-Lyzer, DispoDialyzer or Micro
Dispodialyzer can be used with Spectra/Gel to concentrate samples.
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Appendix 18 - Dialysis and Concentration Protocol
1. The dialysis tube is stored in a 0.1% sodium azide solution which is a neurotoxin so it
needs to be rinsed a few times prior to use with MilliQ water. Please be very careful in
handling the tube during this time as not to come in contact with the sodium azide or
damage the dialysis membrane.
2. Then the sample can be pipetted directly into tube. The cap should be put on tightly and
then the sample should be floated in a large container filled with ice cold PBS. The
solution should sit on top of a spinner table/machine in the cold room, so that a small
metal spinner can circulate the solution n the container.
3. Dialyze for one to three hours, then change the PBS completely with new, ice-cold PBS.
Keep the sample wet during the buffer changes. It's useful to fill a 250 ml Erlenmeyer
Flask with ice-cold PBS and let the dialysis tube sit there temporarily in the Erlenmeyer
flask while making PBS changes.
4. Dialyze for a second time, one to three hours, then change the PBS completely once
again with new, ice cold PBS.
5. Dialyze the third time overnight.
6. When the dialysis is complete, make a small tray out of aluminum foil. Measure out 100
grams of Spectra/Gel Absorbent.
7. Take the Float-a-Lyzer Dialysis Membrane out of the buffer and lay it onto the small
tray, so the cap is outside of the aluminum foil tray.
8. Roll the membrane in the Absorbent powder to coat all sides of the dialysis membrane,
and try to burry the membrane into the pile of Absorbent Powder.
9. Then fold over the walls of the aluminum foil tray, so that the powder and membrane are
enclosed together.
10. Check the volume after one hour, and periodically afterwards, until the appropriate
volume is reached. When checking volume, carefully brush off the gel that has become
moist and try to put the dialysis tube in drier powder, to enhance the concentration.
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